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ABSTRACT
     These experiments were carried out to investigate the effects of some potential key factors 
contributing to the development of osteoporosis (OP) and osteoarthrosis (OA) in animal 
models. These factors include aging, gender, functional joint loading and unloading, and 
different types of gene defects that affect the synthesis and assembly of collagen type II. 
     The effects of long-term running on canine bone were studied in 20 young female beagle dogs. 
Half of them ran on a treadmill for 55 weeks, beginning at the age of 15 weeks. The daily running 
distance increased progressively up to 40 km/day. The unloading effects on bone were studied 
in 34 young beagle dogs. The right hind limb of half of them was immobilized by splinting for 11 
weeks at the age of 29 weeks. The casts were removed at the age of 40 weeks and the dogs were 
then remobilized for 50 weeks. The effects of limb malalignment on bone mineral density and 
remodelling was studied in 44 young female beagle dogs. In 15 dogs, a 30º valgus angulation of 
the right tibia was surgically created, 15 dogs were sham operated and the rest served as controls.
     The effect of knockout inactivation of one allele of the Col2a1 gene on bone remodelling and 
on bone properties after functional loading was studied in 205 C57/BL male and female mice, half 
of which had access to a running wheel. Also, transgenic mice carrying an internally deleted human 
type COL2A1 gene were used to study bone development and growth with 100 FVB/N mice.
     Long-term running exercise resulted in a significant reduction in bone mineral density 
(BMD) in female beagles. However, biomechanical testing showed no differences in the bone 
strength. The collagen fibres of bone were organized in a more parallel manner in the runner 
dogs, although there were no differences in total collagen amount or collagen cross-links. 
     Immobilization of right hind limb for 11 weeks induced a site dependent decrease in BMD 
of the casted limb in association with a reduction of BMD in the contralateral limb. Bone 
histomorphometry revealed decreased bone volume, increased trabecular bone formation and 
resorption. These changes were almost completely reversible after one year of remobilization.
     Valgus osteotomy of the proximal tibia and the joint malalignment led to an increased turnover 
in the subchondral bone and susceptibility to OA changes in articular cartilage. The altered 
biomechanics of the operated limb induced also reduction in the BMD of the proximal femur.
     Defects in the gene encoding collagen type II induced a marked decrease in synthesis of 
normal collagen type II and disturbed normal bone growth and remodelling in mice. This led 
to a reduced bone formation, increased bone resorption, and increased percentage of woven 
bone when studied with histomorphometry. The transgenic animals had lower BMD and 
their bones were biomechanically weaker than their wild-type littermates. The BMD did not 
correlate with the mechanical properties in association with this type of collagen gene defect.
     In this study, we demonstrated the positive effect of functional loading on bones. Short-
term immobilization induced reversible bone loss in growing animals. The important role of 
collagen type II in bone homeostasis, mechanical integrity, and remodelling was also revealed.
National Library of Medicine Classification: QU 450, QY 60.D6, QY 60.R6, WE 250, WE 348
Medical Subject Headings: Biomechanics; Bone and Bones; Bone Density; Bone Remodeling; Collagen; 
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1 INTRODUCTION
Osteoporosis (OP) together with osteoarthrosis (OA) of joints and spine, associated with ageing, 
are an enormous and an ever-growing health problem in the industrialized countries. The diseases cause 
pain, loss of capacity to work and reduced musculoskeletal activity and function. 
OP is characterized by low bone mass and microarchitectural deterioration of bone tissue, with 
a consequent increase in bone fragility and susceptibility to fractures. Although in OP bone loss is a 
systemic condition, the most frequent fractures occur at the hips, vertebrae, shoulder and distal forearms. 
Hip fracture is the most common cause of mortality and morbidity in the osteoporotic fractures; 12–20% 
of hip fracture victims die within the first year after the fracture and more than 50% of the survivors 
become incapacitated (Consensus Development Conference 1991, 1993). There were 7 083 hip fractures 
in Finland in 2004 (Kannus et al. 2006). The costs of the first post-fracture year have been estimated 
to be 14 410 € per patient, with the sum increasing to 35 700 € if the patient needs to be permanently 
institutionalized due to an inability to cope with activities of daily living (Nurmi et al. 2003).
OA is another rapidly growing health problem in our aging population of the western world. 
Idiopathic OA is a debilitating progressive disease leading to damage of the articular cartilage. OA 
affects 60% of men and 70% of women over the age of 65 years with enormous social costs, almost as 
much as that of ischemic heart disease (Roach and Tilley 2007). The onset of OA is multifactorial and 
the initial pathomechanisms are still poorly understood. In 2006, 8.4% of all the disability pensions in 
Finland were granted due to limb OA or rheumatoid arthritis, corresponding to about 21 200 pensioners 
(The Social Insurance Institution of Finland 2007). More than 15 800 total joint replacements needs to 
be performed in Finland every year, mainly on account of primary OA (Finnish Arthroplasty Register 
2008).
It is crucial that we understand better these disorders if we are to find an effective cure for the 
diseases, or even to find ways to prevent them. The use of animal models is the one reliable way to 
control many environmental, nutritional or activity-related factors when investigating the complex 
cascade of different factors that eventually induce the typical appearance of OA or OP. It is known that 
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genetic factors can predispose to OA and OP. Collagen, the major structural macromolecule of bone 
and cartilage, may be defective due to genetical reasons and this can cause structural alterations in the 
connective tissues leading to the pathogenesis of OA and OP. Genomic studies have revealed the clear 
homology between the human and the murine genomes (Waterston et al. 2002). Thus, murine transgenic 
models can be considered to provide a new means to study the role of alterations in collagen amounts, 
structure or fibril network in association with a variety of musculoskeletal disorders (Aszódi et al. 1998b, 
Kuivaniemi et al. 1991, Mann and Ralston 2003, Sokolov et al. 1991). 
The objective of this study was to investigate the association of functional loading, and, also 
disturbance of collagen structure on bone in the development of OA and OP. The effects of functional 
joint loading and immobilization, and the effects of proximal tibial valgus osteotomy, on bone mechanical 
properties, architecture and metabolism were studied in canine models. The influence of altered type II 
collagen structure or synthesis on OA and OP was studied using transgenic mouse models. 
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2 REVIEW OF THE LITERATURE
2.1 Bone biology
2.1.1 Bone development and growth
Bone is a specialized connective tissue that confers mechanical support to the body and also 
represents the sites of muscle attachment. This allows locomotion and mechanical protection of vital 
organs and the bone marrow. Finally, bone is a metabolic reservoir for the entire organism of important 
ions, especially calcium and phosphate (Baron 1993, Recker 1992).
During embryogenesis, the skeletal tissue in humans and higher vertebrates is developed from the 
mesenchymal cells of the mesoderm. The mesenchymal cells can develop into osteoblasts, chondroblasts, 
fibroblasts, and other connective tissue cells. By the gestation time of six weeks in humans, some 
mesenchymal cells have differentiated into chondrocytes and these cells initiate their protein synthesis 
leading to an entire cartilaginous model of the appendicular skeleton being formed (Sadler 1985).
Bone formation can occur via two different pathways: endochondral ossification or 
intramembranous ossification. The cartilaginous bone template, formed by chondroblasts and 
chondrocytes, ossifies by endochondral ossification (Gerstenfeld and Shapiro 1996, Wuthier 1982). 
Undifferentiated mesenchymal cells migrate, condense and differentiate into chondroblasts and 
chondrocytes. The cells proliferate and secrete extracellular matrix components and form the cartilaginous 
bone primordium. The cartilaginous matrix eventually calcifies. Normally the primary ossification centre 
develops in the middle of the bone primordium, the diaphysis. In this process, osteoclasts appear in the 
calcifying tissue. These cells are needed to remove and remodel the calcified cartilage. Subsequently, 
osteoblasts begin to form the lamellar bone. This process continues toward the epiphyses, i.e. the bone 
ends. Endochondral ossification is by far the most common mechanism of bone formation and involves 
the vertebral column, pelvis, base of the skull and the long bones. The intramembranous ossification 
covers the development of the cranial and facial bones. 
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Intramembranous ossification consists of the direct formation of bone from a sheet of mesenchymal 
cells or membrane without any intermediate cartilaginous state. Some mesenchymal cells differentiate 
directly into bone-forming osteoblasts along the membrane and start synthesizing the collagenous bone 
matrix, the osteoid. The collagen fibrils in the newly formed osteoid matrix are arranged randomly. The 
bone tissue produced by this process is called woven bone. During the maturation process, the collagen 
fibrils of the woven bone are replaced with more organized collagen fibrils, thus forming so-called 
lamellar bone. 
After birth, secondary ossification centres develop in the epiphyses of long bones. Simultaneously, 
the cartilaginous, metaphyseal growth plate is formed between the primary and secondary ossification 
centres. The growth plate is a layer of proliferating cells expressing cartilage matrix molecules. This 
tissue gradually undergoes transformation to bone tissue as described above. This process allows bone to 
elongate longitudinally. The growth period comes to end, when the entire growth plate becomes ossified 
and remodeled in early adult life. At this stage the long bones have reached their final length.
2.1.2 Bone structure and chemical composition
2.1.2.1 Macroscopic structure
Bone is a matrix-mineral composite. The matrix and minerals endow bone with its mechanical 
properties. The mineral phase provides stiffness to resist compressive forces, and the protein matrix 
supplies tensional resistance. The macroscopic appearance of the cut surface of a bone near the epiphyseal 
region reveals both trabecular (spongy or cancellous) and dense compact bone. The trabecular bone 
consists of intercommunicating trabeculae forming a porous meshwork-like structure. The bones can 
be divided into two groups: (i) the flat bones including the skull bones, clavicle and mandible, which 
develop through intramembranous ossification, and (ii) the long bones, e.g., tibia, femur, humerus, and 
vertebrae that develop through endochondral ossification. In the long bones, three distinct parts can be 
displayed (Figure 1). The epiphyses of both ends of long bones are the wide parts beneath the articulating 
surfaces. The epiphysis consists primarily of trabecular bone with a thin cortex of compact bone. The 
diaphysis consists of a tubular, more or less cylindrical part between the bone ends. The metaphysis 
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forms the transitional zone between diaphysis and epiphysis and during the growth period this contains 
the epiphysial or growth plate (Gray 1980).
Figure 1. Macroscopic features of sectioned human proximal femur.
The long bones are covered by a thick and dense layer of calcified tissue, the cortex (compact 
bone). At the metaphysis and epiphysis, the cortex becomes progressively thinner and the internal bone 
space is filled with the trabecular bone. The articulating surfaces at the ends of long bones are covered 
with a relatively thin layer of hyaline cartilage. The spaces in the hollow diaphysis, as well as the spaces 
between the bone trabeculae in cancellous bone are filled with haematopoietic bone marrow and/or fat 
tissue.
With the exception of the articular surface, bone is covered by two distinguishable surfaces, 
where the bone is in contact with other tissue types. The endosteal surface is the inner surface facing 
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the fatty bone marrow. The surface facing outwards to muscles or soft tissue is the periosteal surface. 
These surfaces are lined with osteogenic cells organized in layers, the endosteum and the periosteum, 
respectively.
There are structural and functional differences between the compact and trabecular bones. In 
all, about 80–90% of the total volume of compact bone is calcified as compared with only 15–25% in 
trabecular bone. The endosteal surface consists of 70–85% of the total interface with bone marrow. The 
functional differences are a consequence of these structural differences and vice versa. The cortical bone 
fulfils mainly the mechanical and protective function while the trabecular bone is more responsible for 
the metabolic properties.
2.1.2.2 Microscopic structure and bone cells
The functional unit of the cortical bone is the osteon. Each osteon contains a central Haversian 
canal complete with blood vessels, nerves and connective tissue. At the surface of these canals, bone-
resorbing and –forming cells may be seen reflecting bone modelling or remodelling activity within the 
unit. The active remodelling units are also referred to as basic multicellular units (BMU) (Malluche and 
Faugere 1986). 
Cortical and trabecular bones are comprised of the same cells types; osteoprogenitor cells, 
osteoblasts, osteocytes, and osteoclasts. Osteoprogenitor cells are mesenchymal, undifferentiated stem 
cells of bone, which during bone formation, undergo division and transformation into bone-forming 
cells, osteoblasts (Kassem et al. 2008). Osteoblasts form the bone lining cells and are important in bone 
formation, producing the osteoid. The osteoid is the uncalcified collagenous bone matrix. Some of the 
osteoblasts, approximately 10% in all, are totally entrapped in the surrounding matrix. These cells are 
transformed into osteocytes, true bone cells, and thus become the main cellular component of mature 
bone (Malluche and Faugere 1986). Osteoclasts are the giant multinucleated cells derived from the 
haematopoietic stem cells. Osteoclasts are active in bone resorption (Väänänen and Laitala-Leinonen 
2008). Osteocytes are derived from osteoblasts and are embedded deep within the calcified bone matrix. 
These cells, however, are in contact with each other, as well as with cell processes from other osteocytes 
or bone lining cells (Civitelli 2008, Skerry 2008). Their functions are not completely understood, but 
there is an emerging consensus that osteocytes act as mechanosensitive cells translating mechanical 
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strain into signals of bone formation or resorption. They also may act as microenviromental sensors 
modifying the properties of bone and the magnitude of shear stress in the bone fluid, and as regulators 
of phosphate metabolism and bone mineralization (Bonewald 2006, Datta et al. 2008, Fukumoto 2008, 
Noble 2008, Teti and Zallone 2008, You et al. 2008).  
2.1.2.3 Bone minerals and chemical composition
Bone minerals and inorganic matter account for about 70% of total bone weight, water for 5–8%, 
with organic matrix making up the remaining 20–25%. Approximately 95% of the mineral phase is 
composed of needle-shaped crystals of hydroxyapatite [Ca10(PO4)6(OH)2] (Gray 1980). These crystals 
are impregnated with impurities accounting for the remaining 5% of the inorganic phase. The crystals 
are 100 nm in length, 20–40 nm in width and 3–6 nm in thickness (Currey 2002). In general, the 
hydroxyapatite crystals are arranged with their long axis in parallel to those of the collagen fibrils and 
they lie partly within the fibrils or thicker fibres. In addition to calcium and phosphorus, bone contains 
also some trace elements including zinc, fluoride, copper, aluminium, and magnesium (Abbott and Rude 
1993, Jonas et al. 1993, Quarles et al. 1990, Rahn et al. 1991, Reis et al. 1988, Root and Diamond Jr. 
1993).
2.1.3 Bone matrix proteins
Bone and cartilage contain relatively few cells. A major part of their volume is extracellular 
material, which is largely composed of a complex network of macromolecules, forming the extracellular 
matrix (ECM). This matrix is composed of a variety of proteins and polysaccharides that are secreted 
locally and assembled into an organized meshwork in close association with the surface of the cells 
that produced them. ECM proteins of bone can be roughly divided into the collagens and the non-
collagenous proteins.
2.1.3.1 Collagens
Collagens are the most abundant ECM proteins in mammals, accounting for about 30% of the 
total protein mass (Burgeson and Nimni 1992). The collagen fibrils and their larger bundles, i.e. fibres, 
are flexible and have a remarkably high tensile strength. The importance of these proteins is most obvious 
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in connective tissues such as bone, cartilage, ligament, tendon, dermis and dentin, where they provide a 
highly organized fibrous matrix. The collagens also confer structural integrity on the capsules, septae and 
laminae of the gastrointestinal, cardiovascular, urogenital, respiratory, and nervous system (Cole 1994, 
Rahkonen et al. 2003). The collagens are products of a superfamily of closely related genes with several 
characteristic features and a wide range of functions (Myllyharju and Kivirikko 2001). A typical collagen 
molecule has a long and stiff triple helical structure, in which three collagen polypeptide chains (α 
chains) are wound around each other in a rope-like left-handed superhelix. Collagens are distinguished 
from other ECM proteins by their triple-helical conformation (Fields 1995) and they are extremely rich 
in proline and glycine, both of which are important in the formation and stabilization of the triple-helix. 
So far, at least 27 distinct collagen α chains have been identified, each encoded by a separate gene 
(Alberts et al. 2002, Mayne and Ala-Kokko 2005). Collagen types I-III, V and XI are classified as fibril-
forming collagens. Another group of collagens includes types IX, XII and XIV, which are assigned to 
the fibril-associated collagens (FACIT). These collagens have an interrupted triple-helix. Collagen types 
VIII and X appear to form another class of ECM collagens, and they can form regular hexagonal lattice 
structures (Thomas et al. 1994). Rather than summarizing the extensive literature on all of these collagen 
types, this review will focus on the major collagen types of bone and cartilage. 
Collagen accounts for about 2/3 of the dry weight of adult articular cartilage. The supportive 
heteropolymeric collagen fibril network in articular cartilage matrix consists of collagens II, IX, and XI. 
The fibril diameter varies between 15 and 60 nm. Minor amounts of type III, VI, XII and XIV collagens 
have been detected in articular cartilage. The proportion of different collagen types in the fibrils varies 
with age. Especially in the young cartilage, the proportion of the type IX and XI collagens can account 
for as much as 20% of the total collagens, while in mature cartilage the amount of type II collagen 
exceeds 90% (Eyre 2002).
Bone collagen consists almost entirely of type I collagen. The other types are not present in 
anything like the levels found in cartilage and soft tissue. However, several FACITs have been detected 
in bone, as well as low levels of type III and V collagens (Gehron Robey and Boskey 1996).
2.1.3.1.1 Fibril-forming collagens (I-III, V, and XI)
Collagen type I is the most important collagen in bone, accounting for over 90% of the total bone 
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collagen (Bätge et al. 1992). It is a heterotrimer composed of two α1(I) chains and one α2(I) chain. It 
forms the major scaffold of virtually all connective tissues with the exception of cartilage. Two genes 
encode these polypeptides, COL1A1 and COL1A2, with the corresponding peptide sizes being 18 kb 
and 40 kb (Kream et al. 1995). Type I collagen is also found in tendons, intervertebral discs and dentin, 
and it can also be detected in the sclera and cornea of the eye, lungs and the skin (Gehron Robey and 
Boskey 1996). In different tissues, the collagens are not exactly identical, differing in the extent of the 
post-translational modifications. Each triple-helical collagen molecule forms a 300 nm long and 1.4 nm 
wide semiflexible rod that spontaneously assembles into microfibrils (Figure 2). In bone, the osteoblasts 
are the predominant cells expressing the COL1A1 and COL1A2 genes (Gerstenfeld et al. 1993).
Type II collagen is the predominant protein in cartilage matrix. This collagen was first described 
in 1969 (Miller and Matukas 1969). Structurally it is related to the other fibril forming collagens. It 
is a homotrimeric molecule consisting of three identical α1(II) chains encoded by the COL2A1 gene, 
approximately 30 kb in size (Cole 1994). Like other fibrillar collagens, type II collagen is synthesized 
as a procollagen, containing carboxy- and aminoterminal extensions. In the endoplasmic reticulum, the 
polypeptide chains undergo several modifications including hydroxylation of many of the proline and 
lysine residues and glycosylation of hydroxylysines. The propeptides are cleaved off in the ECM. Type 
II collagen is also present in the nucleus pulposus of the intervertebral discs and in the vitreus humour 
of the eye (Aszódi et al. 1998a, Savontaus et al. 1997).  The chondrocytes are the predominant cells 
expressing the COL2A1 gene (Cole 1994, Sandell et al. 1994).
Collagen type III is a delicate thin, widely distributed fibrillar collagen, which is present in dermis, 
blood vessels, and fibrous structures of viscera. It usually emerges in heterotypic fibrils in combination 
with collagens type I and XI. Type III collagen is synthesized or secreted by fibroblasts and smooth 
muscle cells. This protein consists of three identical α1(III) chains. Type III collagen is often considered 
to be a fetal collagen, due to its abundant expression in fetal tissues. However, little is known about its 
role in the development of skeletal tissues (Liu et al. 1997, Niederreither et al. 1994). 
Type V collagen is present in annulus fibrosus of the intervertebral disc. The distribution of this 
collagen in skeletal tissues seems to follow the pattern of type I and II collagens (Eyre 1988). Type V 
collagen resides within the collagen fibril, suggesting that type V collagen may be involved in the initial 
events of fibrillogenesis (Burgeson and Nimni 1992). Type XI collagen is buried in the collagen fibrils 
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Figure 2. Biosynthesis of a fibril-forming collagen. Procollagen polypeptide chains are 
synthesized on the ribosomes of the rough endoplasmic reticulum and secreted into the lumen, 
where they are modified by hydroxylation of certain proline and lysine residues and glycosylation 
before chain association and triple helix formation. The procollagen molecules are secreted into 
the extracellular space where the N-terminal and C-terminal propeptides are cleaved off by 
specific proteases. The collagen molecules then assemble into fibrils, which are stabilized by the 
formation of covalent crosslinks. Reproduced from Myllyharju and Kivirikko 2001.
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of cartilage, where it forms a heteropolymer. It eventually copolymerizes with collagen type II and it has 
been postulated to provide a mechanism for fibril diameter regulation in cartilaginous tissue (Aszódi et 
al. 1998a, Tsumaki et al. 1996). 
Collagen fibrils are stabilized by crosslinks. The crosslinks of bone and cartilage collagens 
are attributable to the lysine and hydroxylysine residues (Eyre 1988). The total amount of crosslinks 
correlates positively with the mechanical properties of bone (Oxlund et al. 1995). It is generally agreed 
that the stability of collagen fibres increases with advancing age (Kim et al. 1994). A variety of human 
conditions, normal and pathological, are based on the ability or failure of tissues to repair and regenerate 
their collagenous mainframe (Burgeson and Nimni 1992). 
2.1.3.1.2 Other collagens
Type IV collagen is the main collagen of basal lamina. Type VI collagen is a trimer of three 
different chains, α1(VI), α2(VI), and α3(VI). It interacts with a number of other ECM molecules, such as 
type I-III collagens, biglycan, decorin, and hyaluronan (HA) (Braghetta et al. 1996). In ECM, the type 
VI collagen forms a network of microfibrillar aggregates with the banded fibers of type I collagen. A 
high ratio of type VI collagen to type I collagen is found in intervertebral discs. The opposite situation 
exists in bone (Braghetta et al. 1996). Type VI collagen is also present in the territorial matrix of hyaline 
cartilage. However, its significance in skeletal tissues is uncertain.
Collagen type IX is a 190 nm long heterotrimer of disulfide-bonded α1(IX), α2(IX), and α3(IX) 
chains. The α2(IX) chain of the collagen type IX contains a covalently bound glycosaminoglycan (GAG) 
chain. This collagen usually co-exists in a periodic fashion along the surface of type II collagen (Wu 
et al. 1992). Type IX collagen may be detected in hyaline cartilage, vitreous humour, sclera and neural 
retina of the eye, inner ear, and notochordal sheath (Cole 1994). In hyaline cartilage, type IX collagen 
seems to be more abundant during development than in adult mature tissue (Eyre 1988).
Collagen type X is a homotrimer of three identical α1(X) chains encoded by the COL10A1 gene. 
The gene expression occurs only in the hypertrophic chondrocytes. The role of collagen type X in the 
development of skeletal tissue is somewhat putative, as no gross abnormalities in long bone growth or 
development have been observed in experimental animals with deficient Col10a1 expression (Paschalis 
et al. 1996, Rosati et al. 1994). 
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2.1.3.2 Non-collagenous proteins
Non-collagenous proteins (NCPs) comprise about 10–15% of the total bone protein content. 
Several NCPs have been identified in bone, including osteopontin, bone sialoprotein, osteonectin, 
osteocalcin, proteoglycans, alkaline phosphatase, bone morphogenetic proteins (BMPs), matrix 
metalloproteins and growth factors (Ingram et al. 1993). About one quarter of the amount of NCPs is 
exogenously derived, being adsorbed or entrapped into the bone matrix (Termine 1993). These proteins 
include various growth factors and albumin.
Osteopontin and bone sialoprotein belong to a family of phosphorylated glycoproteins. They 
both contain the tripeptide sequence Arg-Gly-Asp common to cell attachment type proteins that bind 
the cell surface receptors called integrins (Shinar et al. 1993). Integrins are expressed in osteoblasts and 
osteoclasts and are required in the attachment of these cells to bone (Hughes et al. 1993). Osteopontin 
and bone sialoprotein are believed to influence the cell-matrix interactions and the activity of the cells. 
They have high affinity for calcium and may therefore regulate the deposition of mineral in the bone 
matrix (Gehron Robey et al. 1993, Hultenby et al. 1994, Ingram et al. 1993, Rittling et al. 1998).
Osteonectin is the most abundant NCP produced by bone cells. It is also a phosphorylated 
glycoprotein, accounting for about 2% of the total protein of the developing bone in most animal species. 
It has a high affinity for binding ionic calcium and hydroxyapatite. It is believed to possess multiple 
functions in bone, and appears to be associated with osteoblast growth and/or proliferation and matrix 
mineralization (Termine 1993). 
Bone contains a number of proteins that are post-translationally modified by vitamin K dependent 
enzymes to form the amino acid, γ-carboxy glutamic acid (gla). These proteins include osteocalcin (OC, 
previously called bone gla-protein (BGP)) (Gehron Robey et al. 1993). The function of osteocalcin is 
described in more detail in Chapter 2.1.5 below.
Proteoglycans (PGs) are macromolecules characterized by the attachment to the protein core of 
long chains of repeating disaccharides that are often sulphated, these are termed glycosaminoglycans. 
The glycosaminoglycans include chondroitin sulphate, dermatan sulphate, keratan sulphate, and HA 
(Forriol and Shapiro 2005).  Large aggregating PGs can be found in bone. These include aggrecan 
and versican. Also smaller leucine-rich low molecular weight proteoglycans, decorin, biglycan and 
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fibromodulin, are distributed throughout most connective tissues (Hardingham and Fosang 1992). The 
PGs are important proteins in cartilage, where they bind ions and water and are the major determinants of 
the biomechanical properties of hyaline cartilage in addition to type II collagen. The PGs of bone differ 
substantially from those  present in cartilage, consisting primarily of small glycoconjugates with only 
one or two chondroitin sulphate chains. It is proposed that PGs can provide a strain-related stimulus to 
the various cells, including osteocytes (Bonewald and Johnson 2008, Skerry et al. 1988, Tarbell et al. 
2005).
Alkaline phosphatase (ALP) is not a typical matrix protein. However, a few reports have been 
published, where ALP activity has been isolated from mineralized matrix extracts (Gehron Robey and 
Boskey 1996, Sakano et al. 1993). The specific function of ALP in bone has been debated for more than 
60 years. As knowledge of the structure and function of ALP has increased greatly in recent years, the 
enzyme has been found to play a crucial role in bone mineralization (Hui and Tenenbaum 1998, Millán 
2006).
Bone and cartilage tissues are rich in different growth factors, which participate in the regulation 
of skeletal development and growth. Bone morphogenetic proteins (BMPs) belong to the TGF-β 
superfamily and though they are known to have important function in the differentiation of bone cells 
their exact role in bone remodelling and healing is still a matter of debate (Dimitriou et al. 2006, Elima 
1993, Lind et al. 1996).
Matrix metalloproteinases (MMPs) are a large family of Ca2+-requiring zinc metalloendopeptidases 
that collectively degrade most ECM components (Hayakawa 2002). They play a key role in bone 
development and remodelling, but they are also involved in many pathological conditions, such as 
cancer invasion and metastasis development (John and Tuszynski 2001), arthritis, glomerulonephritis, 
and atherosclerosis. A summary of the proteinases of bone and cartilage is given in Table 1. The activity 
of MMPs is controlled by their natural inhibitors, the tissue inhibitors of metalloproteinases (TIMPs). 
To date, four members of the human TIMP family (TIMP-1, TIMP-2, TIMP-3, and TIMP-4) have been 
characterized (Hayakawa 2002).
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Proteinase Subtypes Major target constituents
Metalloproteinases
Collagenases MMP-1 (interstitial collagenase) Collagens II, III, X, aggrecan
MMP-8 (neutrophil collagenase) PG-link protein
MMP-13 (collagenase 3)
Gelatinases MMP-2 (72 kDa collaginase) Collagens I, X, XI, XIV
MMP-9 (92 kDa collaginase) Aggrecan, PG-link protein
Stromelysins MMP-3 (stromelysin 1) Collagens III, IX, X, aggrecan
MMP-7 (matrilysin, PUMP-1)
MMP-10 (stromelysin 2)
MMP-11 (stromelysin 3)
Membrane type MMP-14 (MT-MMP-1) Collagens II, III, aggrecan
Aggrecanases
Disintegrin and a disintegrin and metalloproteinase Aggrecan
metalloproteinase type with thrombospondin motifs 4 and 5
(ADAM-TS4, ADAM-TS5)
Other proteinases
Elastase cathepsins Cathepsin B & L (cysteine proteases) Collagen telopeptides
Collagen IX, XI, aggrecan, elastin
Cathepsin G (serine protease) Aggrecan, elastin, collagen II
pro-MMPs
Cathepsin D (asparate protease) Phagocytosed extracellular matrix
components
Proteinases of the Tissue plasminogen activator (tPa),
coagulation system Urokinase type plasminogen activator (uPa)
Plasmin Fibrin, fibronectin, aggrecan,
pro-MMPs
Table 1. Proteinases affecting the metabolism of extracellular matrix moleculules of articular cartilage 
and bone.
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2.1.4 Bone modelling and remodelling
Bone modelling and remodelling are important aspects of bone metabolism. In the modelling, 
which takes place principally during childhood, bone undergoes changes in bone size and shape; the 
skeleton grows longitudinally, and bones expand also in diameter. Modelling is the main process by 
which the bone can increase the size and mass of both cortical and trabecular bone. In humans, the peak 
bone mass is usually achieved at the age of 20 years (Currey 2002). During the growth and modelling 
period, the osteoblasts and osteoclasts work independently of each other on different bone surfaces. 
Usually new bone is formed at the periosteal surface, while active resorption occurs at the endosteal 
envelope (Parfitt 1984). The modelling processes are mainly influenced by mechanical loading as well 
as by nutritional and hormonal factors.
In remodelling, which is the main process in the mature tissue, bone formation and resorption are 
linked in space and time. Bone remodelling is important for at least two main reasons. First, it regulates 
the mineral balance of the body by exchanging calcium and other ions from the skeletal reservoir. Second, 
bone remodelling can renew old bone and thus improve the mechanical properties of micro-damaged 
bone. The remodelling process is thought to be site-specific, though the actual factors regulating this 
process are still poorly understood (Currey 2002).
Bone remodelling takes places in BMUs in both cortical and trabecular bone (Frost 1969). 
Ultimately, the basic mechanisms of remodelling are the same for cortical and trabecular bone, even 
though the final three-dimensional structures are totally different for the two bone types.
Bone remodelling can be divided into four consecutive sequences, namely activation phase, bone 
resorption, reversal and formation phases (Figure 3). In the activation phase, osteoclasts are recruited, 
stimulated to differentiate and guided to the resorption site. The regulatory mechanisms of the activation 
phase are multifactorial and partly unknown. However, the osteocytes have a leading role in this process 
which would also mean that they are important in determining the remodelling site (Civitelli 2008, Datta 
et al. 2008, Mann et al. 2006, Noble 2008). A new activation phase in BMU is initiated about once every 
10 seconds (Dempster 1992).
The resorption phase follows the activation phase, in which activated multinuclear osteoclasts 
migrate to the resorption area and become attached to the resorption surface. In the resorption lacuna, 
bone mineral is solubilized using the acidification process before the degradation of bone organic 
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matrix. Degradation of the organic bone matrix utilizes a large variation of proteinases including 
collagenases (Vaes 1988). Table 1 describes the proteinases and their substrates during bone resorption 
in both physiological or pathological conditions. While the ultimate regulatory mechanisms of bone 
resorption remains to be elucidated, it seems logical that during the resorption process, active mediators 
are liberated from the bone matrix or osteoclasts themselves to activate or induce differentiation of 
osteoblasts precursors to the resorption lacuna.
The reversal phase follows the resorption phase and lasts 1–2 weeks (Dempster 1992, Väänänen 
1993). It reverses the processes acting on the bone from destruction to repair and during this time, the 
resorption lacuna is covered by collagen-deficient cement line substance, which will bind the newly 
synthesized bone material to the old surface. The reversal phase is presumably a delicate and important 
period for the coupling phenomenon of bone remodelling (Väänänen 1993). However, the ultimate 
regulatory mechanism has remained unclear.
Figure 3. Bone is remodelled throughout life by a process in which old bone is resorbed and 
replaced by new bone. In postmenopausal osteoporosis, there is typically an increased frequency 
of activation of remodelling sites. New bone formation by osteoblasts is not sufficient to fill the 
remodelling cavities fully. Adapted from IBMS 2008. http://www.bonekey-ibms.org/education/
slides/clinical_osteoporosis/ 
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Bone formation starts with the activation of preosteoblasts which differentiate into osteoblasts. 
The active bone-forming osteoblasts produce osteoid, organic bone matrix consisting mainly of type I 
collagen and non-collagenous proteins and later on, the osteoid becomes mineralized. Complete filling 
of the resorption cavity determines that the bone mass will stay unchanged. If more bone is formed 
than that resorbed, the net balance will be positive. However, usually the histomorphometric analysis 
of bones of old people have shown increased bone resorption and decreased bone formation, creating a 
negative net loss (Reeve et al. 1993). This defect explains the negative bone balance occurring in OP. 
After the formation phase is completed, the remodelling site returns to its quiescent state.
2.1.5 Bone turnover and chemical markers of bone formation and resorption
The mature bone of a full-grown individual is continuously replaced by newly formed bone 
during the remodelling process. Bone turnover depends on biological and geometrical factors (Parfitt 
2002a). Many biological factors are involved in determining the bone formation rate. The bone surface-
to-volume ratio is a geometrical factor that is site dependent. The overall turnover rate is estimated to 
be about 10 % a year (Väänänen 1993). It is highest in the central trabecular bone and lowest at the 
peripheral cortical bone, where the turnover rate difference can be even ten-fold. In general, there are 
marked differences in bone turnover rates in different skeletal sites at different ages and even between 
different races (Brockstedt et al. 1993, Dempster 1992, Podenphant and Engel 1987). Most of the 
turnover occurs at the endosteal surface of bone close to the bone marrow tissue (Baron 1993, Parfitt 
2002a, b).
Bone turnover is regulated by a complex cascade of hormones and active peptides, including not 
only the so-called “calcitropic” agents such as parathyroid hormone (PTH), vitamin D, calcitonin but 
also matrix metalloproteinases, prostaglandins and growth factors (Nagai et al. 1993, Niederreither et 
al. 1992).
Efforts have been made during recent years to create reliable biochemical tests to assay the 
bone formation and turnover. There is one bone-specific isoenzyme of alkaline phosphatase (ALP). It 
is localized at the cell membrane of the osteoblasts and is also released into the circulation though the 
mechanism of its release is unclear. ALP is also released into circulation from the liver, intestine and 
placenta. The wide distribution of the ALP sources limits its clinical use, because it lacks sensitivity and 
34
specificity.  However, serum total ALP activity is the most commonly used marker of bone formation 
(Delmas and Garnero 1996, Seibel 1993).
Serum osteocalcin (OC) is a small non-collagenous protein, which is specific for bone tissue and 
dentin and again, its precise function remains unclear. OC is predominantly synthesized by osteoblasts 
and is incorporated into the extracellular matrix. A fraction of this newly synthesized OC is released into 
the circulation, where it can be measured by radioimmunoassay (Delmas and Garnero 1996, Risteli and 
Risteli 1993). Under most conditions, OC is a valid test for bone turnover when bone resorption and 
formation are coupled. OC is also a good marker for bone formation when formation and resorption are 
uncoupled (Delmas and Garnero 1996).
Markers reflecting the synthesis of type I collagen can also be used as biochemical indicators 
of osteoblast function. These include a test for the carboxyterminal propeptide of type I procollagen 
(PICP) and the aminoterminal propeptide of type I procollagen (PINP) (de la Piedra et al. 1994, Risteli 
et al. 1991, Risteli and Risteli 1993). During extracellular processing of type I collagen, the amino- and 
carboxyterminal propeptides are cleaved off prior to fibril formation. The peptides circulate in blood, 
where they serve as useful markers of bone formation, since collagen type I is a major component of the 
newly formed bone matrix.
Tartrate-resistant acid phosphatase (TRAP) is an enzyme secreted by osteoclasts during bone 
resorption. TRAP activity can also be measured in serum and its activity increases in conditions where 
bone resorption is accelerated. As with ALP, its use is limited by the lack of specificity (Risteli and 
Risteli 1993). Human serum contains two forms of TRAPs, 5a and 5b, of which 5b is derived from 
osteoclasts, and 5a from some other, still unidentified, source (Halleen et al. 2000).
Hydroxyproline (HP) is found only in collagen where it represents about 13% of the amino acid 
content of the molecule. The breakdown of the collagen matrix can serve as an indirect method to analyze 
the extent of bone resorption. HP can be determined from urine samples by high performance liquid 
chromatography (HPLC). Another amino acid unique to collagens and proteins containing collagen-like 
peptides is hydroxylysine. It can also be detected by HPLC (Delmas and Garnero 1996, Gough et al. 
1994, Grazioli et al. 1993).
A major development improving the specificity of the assessment of bone resorption came about 
with the introduction of assays for collagen crosslinks containing pyridinium residues. Pyridinoline 
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crosslinks have been found in fibrillar collagens from several tissues, but they are particularly 
characteristic of the type I and II collagens. Since the crosslinks are specific for fibrillar collagen, the 
pyridinoline crosslinks cannot be derived from the degradation of recently synthesized collagen. The 
levels of pyridinoline crosslinks are usually analyzed using HPLC (Colwell et al. 1993, Delmas and 
Garnero 1996, Risteli and Risteli 1993, Seibel et al. 1993, Seyedin et al. 1993).
2.1.6 Skeletal adaptation to functional loading
There is known to be a structure-function relationship maintained in the bone tissue. According to 
the Wolff’s law all changes in the biology and function of a bone are followed by changes in the internal 
structure and external conformation of the bone in accordance with a mathematical model (Kushner 1940, 
Prendergast and Huiskes 1995). The generation of bone properties are achieved through mechanically 
adaptive modelling and remodelling. In principle, bone is removed from sites where the mechanical 
demands from the skeleton are marginal and formed at sites experiencing increased mechanical loading.
Skeletal adaptation to mechanical loading is homeostatically regulated (Figure 4) (Frost 1998). 
The orthopaedic surgeon Harold M. Frost (1921–2004) stated in his mechanostat theory that increased 
mechanical loading increases bone modelling and reduces remodelling. The modelling occurs in the 
periosteal and endosteal surfaces. The remodelling, however, takes place in the cortical bone and endosteal 
surface (Frost 1990a, b). Modelling or remodelling continues until a new steady state is attained.
Another theory involved in the structure-function adaptation of bone is based on 
mechanotransduction. The central concept of this theory is the transfer of the mechanical loading-induced 
stimuli to chemical and/or electrical signals and eventually to cell and tissue responses. According to this 
theory, the viscoelastic properties of bone induce fluid flow through the interstices of bone, either directly 
by local deformation or by electrical effects related to streaming potentials, mediating the mechanical 
signal (Beck et al. 2002). However, details of this phenomenon are still poorly understood.
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Figure 4. Schematic presentation of the mechanostat theory. The mechano-biologic feedback 
mechanism functions under the control of the subject’s mechanical usage, adjusting skeletal ar-
chitecture in the way that tends to prevent structural failures of skeletal tissues and organs. MFL 
means the mechanical feedback loop, IM stands for intermediary mechanisms, in other words the 
mechanostat’s central unit or decision-making centre. Adapted from Frost (1998).
2.2 Biomechanical properties of bone
Bone is a unique composite material. It can withstand a considerable mechanical load especially 
in comparison to its slender structure. Its lightness makes bone an ideal structure for biological 
organisms. The differently shaped and sized bones of the skeletal system are under strict genetic control. 
In addition, endogenous hormonal, nutritional and environmental factors influence the bone architecture 
and mass (Howard et al. 1998). During physical activity, complex distributions of forces are applied to 
the skeleton. Due to the imposition of these forces, bones undergo deformation and remodelling. 
Since bone is an anisotropic material, its elastic properties depend on the orientation of the 
inherent material with respect to the loading direction, in contrast with isotropic materials (e.g., steel and 
rubber), where the elastic and material properties are the same in all directions.
Any treatment that can change the structure or composition can affect the mechanical properties 
of bone. Even changes in the water content of bone, or different sample storage methods, can alter its 
mechanical properties (Callaghan and McGill 1995, Linde and Sørensen 1993, Turner and Burr 1993). 
The material properties can be defined by its tissue-level qualities, independent of the macroscopic 
structure, size or geometry of bone. This method can be used in the determination of the mechanical 
properties with prepared bone samples. On the other hand, the gross structural properties of bone describe 
the tissue as a whole anatomical unit (Einhorn 1992, Martin 1991). 
LOADS               SKELETON               SIGNALS               (IM)                BIOLOGIC MECHANISMS/ACTIVITIES
MFL
Systemic and nonmechanical agents
Amino acids Hormones Vitamins
Blood pH Blood osmolality Blood gases
Minerals Cytokines Drugs
Fluoride Apoptosis Toxins
Carbonhydrates Proteins Lipids
Cell-cell interactions Cell-intercellular matrix interactions
Other synthetic agents Gene expression Disease
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2.2.1 Stress and strain
During mechanical testing, the bone samples generate an internal force to resist the testing load. 
The original shape of bone becomes deformed. The force and the deformation can be expressed by two 
basic quantities: stress and strain. Stress is defined as force per unit area. In qualitative terms, it can 
further be divided into compressive, tensile, or shear stress (Turner and Burr 1993). Compressive stress 
is produced when a compressive force causes bone to become shorter. A tensile stress occurs when the 
forces act in opposite directions. Shear stress is produced when two forces are acting in parallel with 
each other, but in different directions (Figure 5). The paper-cutting ability of the scissors is an everyday 
example of shear stress. In real life, these three basic stress types may act alone, or in combination. 
Actually bone bending is a combination of compressive and tensile stress. Torsion force adds a shear 
stress component along with the longitudinal axis of the bone.
Strain describes the resulting deformation in shape and size, when the bone is subjected to force. 
Unlike stress, strain is a scalar and dimensionless quantity and is usually recorded as percentage change 
from the original bone dimension (Turner and Burr 1993). The proportionality of stress and strain is 
called Hooke’s law in physics after Robert Hooke, a contemporary of Sir Isaac Newton in the 17th 
century (Young and Freedman 2004).
Figure 5. Typical deformation curve from the three-point bending test of the murine femoral 
diaphysis (A).  Fu = ultimate load to break the bone, K = elastic stiffness of bone, B = ultimate 
displacement before break, and A = ultimate energy needed for break. During the test, the ends of 
the femoral diaphysis are supported by two fulcra separated by a fixed distance of, e.g., five mm (B).
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2.2.2 Stiffness and elastic modulus
The load-deformation curve (Figure 5) can be divided into two regions; elastic and plastic 
deformation regions. The slope of the load-deformation curve within the elastic deformation region 
reflects the extrinsic stiffness or rigidity of the structure. When the load-deformation curve is converted 
into a stress-strain curve, the slope in the elastic region represents the elastic modulus, which is also 
called the Young’s modulus of elasticity. Young’s modulus is a measure of the intrinsic stiffness of the 
material (Turner and Burr 1993, Young and Freedman 2004).
The elastic and plastic strain regions of the stress-strain curve are divided by the yield-point. 
Up till this point, the load and deformation are linearly related. If the load is further increased, then the 
specimen begins to undergo permanent deformation and eventually fails at the point of ultimate stress 
or strain.
2.3 Biomechanical testing of bone
The history of the mechanical testing of bone goes back more than a century. One of the first 
scientists who measured effects of various loads on bone dimensions, density, and displacement was 
Wertheim in 1847 (Jämsä 1998). He observed that the deformation was proportional to the load applied 
to the sample. Since then, several different laboratory methods have been developed to determine the 
mechanical properties of bone. Today, mechanical testing is usually performed using screw-driven, 
pneumatic electrical, or servo-hydraulic testing machines (Turner and Burr 1993). Some of the most 
frequently used regimes include the methods of compression, three- or four-point bending, torsion, and 
tension testing (Jämsä et al. 1998a, Jämsä et al. 1996, Turner and Burr 1993). The mechanical properties 
of whole bones as well as prepared bone samples are assessed with these testing methods.
2.3.1 Compression and tension
The compression test is suitable for bone samples, which are exposed to compressive forces in 
vivo. A typical anatomical site is the vertebral body, the mechanical properties of which can be tested 
by compression. Cylindrical and cubic specimens from cortical or trabecular bone can also be tested by 
compression. Compression is typically performed using a specimen with trimmed parallel surfaces and 
compressing it between two steel plates (Turner and Burr 1993).
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The validity of this test depends critically on the sample preparation and geometry, and the 
results can be altered by variations in the specimen architecture at its trimmed ends, interface conditions 
between the specimen and the plate, the Poisson’s ratio, and other factors such as the preconditioning 
protocol prior to the test (Keaveny and Hayes 1993, Keaveny et al. 1997, Linde et al. 1992). This is 
extremely important when trabecular bone specimens are to be analyzed (Keaveny et al. 1997, Odgaard 
et al. 1989, Odgaard and Linde 1991).
Tensile strength testing has also been applied to bone samples (McCalden et al. 1993, Wang et 
al. 1998). Tensile strength test is a sensitive indicator of fracture healing (Walsh et al. 1997). However, 
tensile tests are more often used to test the mechanical properties of ligaments and tendons (Lin et al. 
1999, Meikle et al. 1984).
2.3.2 Torsion and bending
In a torsion test, the whole diaphyseal bone is twisted from the ends of the specimen. Torsion 
testing is regarded as the best testing method for long bones, because a torsional load subjects the bone 
to equally heavy loading at every section along its length, thus making it possible to identify the weakest 
bone site (Burstein and Frankel 1971). Torsion loading consists of tensile, compressive, and shear forces, 
each acting at different planes in the same region of bone (Lepola et al. 1993). The bone ends are usually 
secured by embedding them in blocks of plaster, epoxy, fibreglass resin, a low melting point metal alloy 
or some other embedding material, though fixation with clamps has also been employed (Jämsä and 
Jalovaara 1996).
Bending loading of long bones is actually a combination of compressive and tensile forces acting 
on the object of interest. The compressive force vector is situated at the site of intender contact and the 
support fulcra in three- and four-point testing devices (Figure 5). The tensile forces produce their effect 
on the opposite side of the specimen. There is a point within the sample where these forces neutralize 
each other. Bone is weaker in resisting tension than compression, and therefore a bending failure usually 
occurs on the tensile side of the bone (Martens et al. 1986, Turner and Burr 1993). The applied force is 
recorded at the time of fracture.
Methodological problems may arise in the three-point bending test, as there a remarkable shear 
stress component may be present in the predetermined fracture point that is situated directly under the 
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indenter head. On the other hand, four-point testing is more difficult to perform accurately, due to the 
difficulty of achieving equal forces in all loading points when an entire long bone is tested (Turner 
and Burr 1993). With the irregularly shaped murine bones, three-point bending is the preferred method 
(Turner and Burr 1993). There is also a method to test the properties of the femoral neck bone. This 
technique mimics the events occurring in the femoral neck fracture of a patient (Jämsä et al. 1998b, Peng 
et al. 1994). 
2.4 Bone densitometry
2.4.1 History of bone densitometry
Historically, before the introduction of bone densitometry, bone mineral content and bone mass 
were determined by burning dried and pulverized bones at a high temperature and then weighing the 
remaining ash, the inorganic mineral content (Chang and Bloom 1983, Martin 1967). 
The history of bone densitometry actually was initiated by the physicist and later Nobel Prize 
winner Wilhelm Conrad Röntgen (1845–1923), Dean at the Julius Maximilian University of Würzburg 
and holder of the chair of physics, who discovered X-rays in 1895. X-ray images provided an early 
opportunity to assess bone quality, although due to various sources of error, the estimations were often 
rather inaccurate (Nilsson et al. 1990).
Although bone ashing provided an accurate measure of bone mass, this method has gradually 
been replaced by bone densitometry. The first innovation was the use of single- (SPA) and dual photon 
absorptiometry (DPA) in the 1980’s to assess the bone mass in a non-invasive manner (Cameron and 
Sorenson 1963, Castelo-Branco et al. 1993, Eriksson et al. 1988, 1989, Kelly et al. 1988, Li et al. 1990, 
Peppler and Mazess 1981, Shipp et al. 1988, Ørtoft et al. 1993). The next step forward, the dual-energy 
X-ray absorptiometry (DXA), became available at the beginning of the 1990’s (Mazess et al. 1990).
The invention of the computed tomography (CT) has been considered to be the greatest innovation 
in the field of radiology since the discovery of X-rays. This cross-sectional imaging technique provides 
diagnostic radiology with better three-dimensional resolution. In 1979, G.N. Hounsfield and A.M. 
Cormack were awarded the Nobel Prize in medicine for the invention of the CT. Since CT-imaging is 
based on X-ray absorption in imaged objects, it was also found to be suitable for estimation of tissue 
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densities (Cann and Genant 1980, Genant and Boyd 1977).
The single energy X-ray attenuates exponentially in a homogenous medium as follows:
(1),
in which I0 is the intensity of incoming photon radiation, x is the thickness of the homogenous 
medium, and μ is the medium-specific coefficient of attenuation. From this equation, the unknown 
variable μ can be computed as follows:
(2).
2.4.2 Dual-energy x-ray absorptiometry
Currently, DXA is a widely used method to evaluate bone mineral density and to determine which 
patients are at risk of osteoporotic fractures (Ito et al. 1993, Mazess et al. 1990). Furthermore, it has also 
been used in many studies to evaluate new therapies for osteoporosis and in animal models predicting 
the mechanical properties of bone (Järvinen et al. 1998). The advantages of the DXA technique include 
the low radiation dose (typically < 1µSv per scan), short scanning time, low cost, high precision and low 
coefficient of variation (Johnson and Dawson-Hughes 1991, Mazess et al. 1990).
The technical principle of DXA-scan is based on the use of two different X-ray energy bands 
(typically 38 and 70 keV). The two energies utilized allow discrimination of the soft and hard (bone) tissues 
in the scan area. This minimizes errors due to an irregular body contour and soft tissue inhomogenities. 
According to equation 1, the attenuation of the dual energy x-ray can be calculated as follows:
  (3)
  (4),
where I0 is the intensity of original x-ray radiation, I is the intensity of attenuated radiation, M mass of 
medium per area unit (g/cm2), and μ is the attenuation constant of the medium (cm2/g). Subscripts 38 
and 70 determine the attenuation at specific energy levels (keV). The subscripts s and b refer to mass of 
soft tissue and bone, respectively. Furthermore, the mass and ratio of the attenuation constants (R) can 
be determined as follows:
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   (8).
 
The R-value is the ratio of soft tissue attenuation at 38 keV compared to that at 70 keV. A typical ratio 
is 1.40. High values indicate that there is less subcutaneous fat in a lean subject. Lower values reflect 
obesity. 
The amount of bone in the beam path is calculated typically as bone mineral content in density 
(BMD). BMD (g/cm2) is usually multiplied by the scanned bone area (cm2), and the calculated bone 
mineral content (BMC) in the region of interest (ROI) is expressed in grams and often, also the scanned 
bone area will be reported (Koo et al. 1995). With the introduction of high resolution software, DXA 
has been successfully applied in animal studies, including bovine (Oden et al. 1998), monkey (Jayo et 
al. 1994), dog (Markel and Bogdanske 1994, Puustjärvi et al. 1992), swine (Yang et al. 1998), and rat 
(Bateman et al. 1998, Järvinen et al. 1998, Kastl et al. 2002, Vanderschueren et al. 1993) bones, and even 
histological bone sections (Denissen et al. 1996). 
2.4.3 Peripheral quantitative computed tomography
Today peripheral quantitative computed tomography (pQCT) can be used to obtain high-resolution 
three-dimensional images (Mueller et al. 2008). The tomographic X-ray information is quantified pixel 
by pixel. Thus, by using pQCT, the true volumetric BMD (vBMD) can be determined. This method 
€ 
Ms = Rb ln
I70
I0(70)
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ −
ln I38I0(38)
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
μs(38)μs(70)Rb
⎛ 
⎝ 
⎜ 
⎜ 
⎜ 
⎜ ⎜ 
⎞ 
⎠ 
⎟ 
⎟ 
⎟ 
⎟ ⎟ 
€ 
Mb = Rs ln
I70
I0(70)
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ −
ln I38I0(38)
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ 
μb(38)μb(70)Rs
⎛ 
⎝ 
⎜ 
⎜ 
⎜ 
⎜ ⎜ 
⎞ 
⎠ 
⎟ 
⎟ 
⎟ 
⎟ ⎟ 
€ 
Rs =
μs(38)
μs(70)
€ 
Rb =
μb(38)
μb(70)
43
allows also an accurate and precise determination of the cross-sectional geometry of a bone section, 
including the cross-sectional moment of inertia (CSMI) of long bones.
The bone strength index (BSI) determined by pQCT, calculated from formula CSMI x vCtBMD, 
correlates closely with the breaking force of the femoral shaft in experimental studies (Ferretti et al. 
1996). The elastic modulus of bone, however, correlates strongly but negatively with CSMI, while the 
ultimate fracture force and stiffness show a positive correlation with the pQCT parameters (Ferretti 
1995).
2.4.4 Quantitative magnetic resonance imaging
The growing awareness of the role of parameters other than BMD in determining the bone strength 
and fracture susceptibility has spurred the search to find new methods to characterize bone quality, in 
particular techniques that would be non-invasive. High-resolution magnetic resonance imaging (MRI), 
in conjunction with advanced image processing and analysis techniques, which are capable of extracting 
structural information at the limited spatial resolution achievable in vivo, has demonstrated significant 
potential to achieve this goal. MRI reveals bone architecture, relating to both trabecular and cortical 
bone. However, the current limitations relate to availability and cost, but these are likely to be overcome 
in future with the development of dedicated instruments (Kröger et al. 1995c, Wehrli 2007).
2.4.5 Bone ultrasound
Ultrasound (US) has been investigated as another alternative method free of ionizing radiation for 
achieving a non-invasive assessment of the biomechanical competence of bone. The rationale of using 
US rests on two basic properties of US. First, its interaction with the material can be used to determine 
the US velocity and the density of the tissue. This makes it possible to characterize the elasticity of bone 
and to estimate its strength. Second, US may be used to characterize tissue properties over a wide range 
of spatial dimensions and organization levels (Hans et al. 1999, Kröger et al. 1995b). Furthermore, it is 
an economic and safe way to estimate bone quality.
Bone US measurements in clinical practice are usually performed from calcaneus, because it is 
easily available. Calcaneal US correlates fairly well (r = 0.6–0.8) with BMD of the lower lumbar spine 
and femoral neck (Kröger et al. 1995b, Yamada et al. 1993) and predicts osteoporotic fractures (Huopio 
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et al. 2004). US signal information is dependent on trabecular orientation and thus it does provide some 
information about bone architecture. However, ultrasonic bone measurements are a relatively recent 
development, and for many of the clinical devices in use today, interpretation of the values produced by 
the device remains a challenge. Therefore, further research is needed into the clinical relevance of the 
numerous parameters provided by US measurement (Glüer et al. 1993, Glüer et al. 1994, Kröger et al. 
1995b, Nicholson 2008).  
2.5 Osteoporosis
Osteoporosis is recognized as a major public health problem in many countries, particularly in the 
United States and northern Europe. Together with another general musculoskeletal disorder, osteoarthrosis, 
OP is responsible for significant health care costs (Holroyd et al. 2008). The term osteoporosis refers to 
a group of conditions where the bone mass and structure are altered, increasing the risk for fracture. The 
current view is that the age-dependent (primary type II or senile) OP is caused by a gradual loss of bone, 
leading to osteopenia. In the criteria published by the World Health Organization (WHO), OP is defined 
as a state in which the BMD of a person is at least 2.5 SD (standard deviation of mean) below the BMD 
of an average healthy individual of the same gender aged 20 to 40 years. Severe OP is a condition where 
osteoporotic BMD exists with one or more osteoporotic bone fractures. Postmenopausal (primary type I) 
OP is associated with increased activity of bone resorption, while in type II OP, reduced bone formation 
is a typical finding. Secondary OP is caused by administration of pharmaceutical agents, by diet, diseases 
or due to other related conditions (Marcus 1992). The relative proportions of the organic and mineral 
phases of bone remain constant even in the trabeculae of osteoporotic bone (Bätge et al. 1992, Oxlund 
et al. 1995). As well as the bone mass, the mechanical properties of bone depend on the architecture and 
structure of the inorganic and organic component (Boonen et al. 1995).
Though, it is believed that genetic factors contribute to the risk for OP (Ferrari 2008), there is 
a lack of information about the mechanisms and specific genes contributing to the development of OP 
(Brown and Duncan 1999, Kung and Huang 2007). Heredity is an important determinant of the bone 
mass determined by densitometry (Evans et al. 1988, Kröger et al. 1994). According to data from family 
studies, hip fractures in a woman’s mother, sister or maternal grandmother at least doubles her risk 
for a fracture in the future (Cummings et al. 1995). The lower incidence of OP in men is due to their 
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higher peak bone mass, shorter life expectancy and the absence of a distinct menopause-equivalent, 
andropause, which would cause marked acceleration of bone loss. However, 20–25% of all hip fractures 
are found in men as are one-seventh of all osteoporotic vertebral compression fractures (Jackson 1993, 
Kaufman and Goemaere 2008).
OP incurs expenses on the public health budget by increasing osteoporotic fractures of hip, 
proximal humerus, distal radius and thoracolumbar spine in elderly citizens in context with low-energy 
trauma. These fractures represent one of the most important causes of disability and death in these 
individuals. The incidence of hip fractures increases exponentially with age. In Finland, the number of 
hip fractures has increased steeply over the last 30 years, in 1970 these were 1857 hip fractures reported 
and in 1997 the number had risen to 7122 (Kannus et al. 1999, Kannus et al. 2000). If the prediction 
of Kannus et al. holds true, the number of hip fractures will be almost three times higher in the year 
2030 (Kannus et al. 1999). This would create an almost overwhelming financial burden due to OP and 
related fractures. However, recent statistics about the number and incidence of hip fractures indicate that 
a steady state, or even a decline in incidence, has been achieved (Kannus et al. 2006). If the incidence 
of hip fractures were to become stabilized at the year 2004 level, the number of hip fractures in Finland 
would still be about 12 600 in the year 2030 (Kannus et al. 2006).
2.6 Models of experimental osteoporosis
2.6.1 Effect of exercise on bone
Bones undergo continuous modelling and remodelling in response to mechanical and metabolic 
demands (Currey 2002).The positive effects of physical exercise on a healthy bone have been well-
documented in several clinical and experimental studies (Chen et al. 1994, Mosekilde et al. 1994, 
Nordsletten et al. 1993, Puustjärvi et al. 1995, Shimegi et al. 1994, Søgaard et al. 1994). There is evidence 
that physical exercise can inhibit, or reverse, the involutional bone loss from the lumbar vertebrae in 
normal postmenopausal women and can also prevent spinal OP (Krølner et al. 1983). However, the 
threshold levels of activity associated with either positive or negative changes are still unknown (Currey 
2002, Forwood and Burr 1993).
Growing bone has a greater capacity to form new bone than the adult tissue (Yeh et al. 1993). 
46
Thus, exercise that increases bone strength and peak bone mass in children and adolescents is able to 
improve bone quality when these individuals are elderly adults (Frost 1999, Welten et al. 1994).
The bone gain in response to exercise seems to depend on certain conditions and types of exercise 
(Haapasalo et al. 1994). Weight-bearing exercise such as running (Lane et al. 1986), weight-lifting 
(Karlsson et al. 1995), or ballet dancing (Karlsson et al. 1993) are more effective than non-weight-
bearing exercise (e.g., swimming) (Matsumoto et al. 1997). This emphasizes the importance of impact-
type training as a way to enhance bone mass (Grimston et al. 1993, Heinonen et al. 1993, Nordström et 
al. 1998, Pettersson et al. 1999).
Negative effects of strenuous physical training have been documented in humans. In female 
marathon runners, the decrease of BMD in the lumbar spine was associated with amenorrhea (Drinkwater 
et al. 1984, Hetland et al. 1993, Jonnavithula et al. 1993, Marcus et al. 1985, Myburgh et al. 1993). 
Strenuous training reduces longitudinal bone growth and induces bone loss in growing rats. The bone 
loss seems to be caused by decreased osteoblastic activity rather than a more general adaptation of the 
bone to remodelling (Bourrin et al. 1994). It has been suggested that excessively vigorous mechanical 
usage increases bone remodelling due to an elevated level of bone microdamage (Bentolila et al. 1998, 
Frost 1990b).
The exact mechanism by which physical activity increases bone mass is still unknown and there 
is a need for better understanding of the adaptive mechanisms of bone to mechanical stress and to 
determine the optimal level and modality of physical activity (Rockwell et al. 1990, Suominen 2006). 
The response of bone to weight-bearing exercise appears to be site-specific (Tommerup et al. 1993). 
Cessation of physical exercise reduces the gained bone mass to normal so that long-term benefits are 
only maintained with continuing exercise (Karlsson et al. 1995).
It should be remembered that there are also other benefits to be obtained from improved fitness 
and muscle strength in addition to bone mass gain. These benefits include improvements in the body 
balance and stability (Karinkanta et al. 2008). In addition, the reaction and muscular response time are 
shortened, which can be more important in preventing falls and reducing fracture risk than any increment 
of bone mass per se.
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2.6.2 Effect of immobilization on bone
BMD is one of the several methods, that can be used to study the effect of physiological unloading 
on bone architecture, biomechanical properties, and markers of bone metabolism. The unloading effect 
can be induced by casts of plaster of Paris or other material, tail suspension apparatus, utilizing a 
microgravity environment, and by neural damage or neurectomy.
2.6.2.1 Disuse osteopenia
The immobilization-induced osteopenia has been studied intensively (for review see Kannus et al. 
(1992a, b)) and atrophic changes in tendons, ligaments and cartilages induced by immobilization, have 
also been reported. In the bones of dogs, three consecutive steps have been described in experimental 
studies (Jaworski et al. 1980). First, a rapid bone loss takes place reaching a maximum at six weeks. 
This is followed by a rapid recovery, with contributions of periosteal, endosteal and Haversian surfaces. 
During the second stage, a slow but long lasting bone loss occurs over a time period of 24 to 32 weeks. 
The loss occurs mostly at the periosteal envelope. In the third stage, the bone mass is maintained at a 
level corresponding to 30 to 50% of its original amount (Uhthoff and Jaworski 1978).
The first two stages of immobilization may represent a stage of reversible osteopenia. There is 
a decrease of the volume of mineralized bone due to the expansion of the bone remodelling space. The 
third stage may be a reflection of permanent osteopenia, i.e. true OP. In this stage, total bone volume and 
other components of bone, e.g., trabeculae have been irreversibly lost (Jaworski et al. 1980). During the 
first stage rapid bone resorption occurs by the action of the increased number of osteoclasts, the enlarged 
osteoclast surface and the sustained decline in the bone mineral apposition rate (MAR) and the reduced 
bone formation rate (BFR) (Weinreb et al. 1989).
Since trabecular bone turnover is more rapid by a factor ranging from 10 to 100 than the turnover 
of cortical bone, the immobilization-induced skeletal alterations are probably more rapid and are more 
striking in trabecular than in compact bone (Frost 1969).
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2.6.2.2 Weightlessness
 Studies from space flights over the past three decades have revealed changes in mineral 
metabolism and bone mechanical properties during prolonged weightlessness. Long-term exposure to a 
microgravity environment causes 10 to 20% loss of BMD, up to 25% loss of muscle mass, cardiovascular 
deconditioning, fluid shift to the upper body, anaemia, and reduced immune function (Hughes-Fulford 
1993, Lane et al. 1993). Continuous negative calcium balance (140–200 mg/day) induce monthly losses 
of BMD in lumbar spine, femoral neck, trochanter, pelvis, and legs (1.1%, 1.2%, 1.6%, 1.4%, and 0.3%, 
respectively) (LeBlanc et al. 2007). Interestingly, the distal radius seems to be resistant to mineral loss. 
After the space flight, bone recovery occurs, but at a slower rate than the rate of loss during space flight. 
The final recovery of bone may require 1 to 3 years after the flight, and even then the recovery may not 
be complete.
 Prolonged bed rest has been used as ground-based model of a space flight to study the nature of 
disuse osteopenia and to test possible countermeasures. The bed-rest induced changes in BMD, calcium 
excretion, calcium balance, and bone metabolic markers are qualitatively similar to those documented 
in space flights, even though quantitatively the changes are of a lesser degree (Krølner and Toft 1983, 
LeBlanc et al. 1987, LeBlanc et al. 2007, Lueken et al. 1993, Uebelhart et al. 2000). The femoral arterial 
blood flow decreases as much as 40% in the rat tail-suspension model of microgravity pointing to a role 
for changes in blood flow in the etiology of muscular atrophy and bone loss (Roer and Dillaman 1994).
2.6.2.3 Neurectomy or paralysis
The effects of long-term immobilization of the lower limbs have been studied on patients with 
hemiplegia (del Puente et al. 1996) and spinal cord injury (Dionyssiotis et al. 2007). Hemi- or paraplegia 
creates a sudden immobilization of the lower limbs. However, the pathophysiology of OP in spinal 
cord-injured patients is complex. There is some evidence that the nervous system would participate 
in the skeletal development and turnover (Takeda 2005). Dionyssiotis et al. reported a loss of BMD 
in the epiphyseal region of tibia of up to 57.5% in high and 51% in low paraplegics as compared with 
their age-matched controls. The cortical thickness of tibia decreased by 21.4% and 23.2%, respectively 
(Dionyssiotis et al. 2007).
Cutting of the sciatic nerve has been used to provoke immobilization-induced bone loss of one 
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lower limb in experimental animals (Garcés and Santandreu 1988, Iwamoto et al. 2002, Suyama et al. 
2002). However, the results of neurectomy on BMD have proved quite difficult to interpret, because 
there are several confounding factors.  The role of the nervous system is not fully understood and it 
is possible there are also systemic factors associated with regulation of mineral homeostasis. After a 
tibial shaft fracture, the sciatic nerve resection protects the femoral shaft against normally occurring 
post-traumatic bone loss (Madsen et al. 1996). Neurectomy of a peripheral nerve does not either affect 
the longitudinal bone growth in rats (Garcés and Santandreu 1988). However, Iwamoto et al. reported 
that briefly after neurectomy, bone resorption increased and bone formation decreased, resulting in a 
reduction of trabecular bone mass (Iwamoto et al. 2002). 
2.6.3 Collagen gene defects and bone
Defects in collagen type I create the typical appearance of osteogenesis imperfecta, in which 
the bones are brittle and susceptible to fracture (Bonadio et al. 1990, Fratzl et al. 1996, Prockop et al. 
1994, Saban et al. 1996). Mutations in type II collagen provoke various types of chondrodysplasias, OA 
and Stickler’s syndrome, where ocular manifestations and spinal deformations are the most prominent 
features (Sahlman et al. 2001, Savontaus et al. 1996). Ehlers-Danlos syndrome is a heritable generalized 
connective tissue disorder that is characterized by skin hyperextensibility, fragile and soft skin, delayed 
wound healing with the formation of atrophic scars, easy bruising and generalized joint hypermobility 
(Sokolov et al. 1991). Recently, mutations in the COL5A1 and the COL5A2 gene were identified in 
approximately 50% of patients with a clinical diagnosis of classic Ehlers-Danlos syndrome (Malfait and 
De Paepe 2005). Mutations of the type III collagen gene have also been reported in the vascular variant 
(type IV) of Ehlers-Danlos syndrome (Callewaert et al. 2008, Gdynia et al. 2008).   For a review of 
animal models in ECM diseases see Aszódi et al. (1998b).
2.6.4 Effect of estrogen deficiency on bone
Estrogen deficiency in postmenopausal females or after ovariectomy, may lead to an accelerated 
bone loss and ultimately to OP (Järvinen et al. 2003b). However, the precise mechanism of action of 
estrogen in bone is not clear. Estrogen can regulate bone metabolism by multiple mechanisms, having 
direct effects on osteoblasts through estrogen receptors, but also it may attenuate the bone resorption-
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stimulating pathway (Majeska et al. 1994). Thus, estrogen plays an important role in the treatment of 
postmenopausal OP (Rozenberg et al. 1994).
Postmenopausal bone loss is on average 2–3% per year and this can be divided into two separate 
phases. First, an accelerated, though transient, phase occurs during the decade after the cessation 
of the menstrual cycles accounting for 20–30% loss of trabecular and 5–10% loss of cortical bone. 
Subsequently, a gradual and continuous phase takes place causing bone loss of up to 20–30% in both 
trabecular and cortical bone (Nordin et al. 1990, Riggs et al. 1998).
2.7 Osteoarthrosis
OA is a common progressive degenerative disease of joint cartilages. It is defined by the American 
College of Rheumatology as a “heterogenous group of conditions that lead to joint symptoms and signs 
which are associated with defective integrity of articular cartilage, in addition to related changes in 
the underlying bone at the joint margins”. OA is usually classified as a primary or idiopathic disease 
when there are no obvious predisposing factors, and a secondary disorder when those factors exist, e.g., 
previous intra-articular fractures. Primary OA is the most common form of the disease, affecting 60% 
of men and 70% of women over the age of 65 years. This incurs enormous socioeconomic costs (Sarzi-
Puttini et al. 2005). As the baby-boomers reach middle age and the obesity continues to increase in the 
general population, OA will have an ever greater impact on the populations in western countries (Roach 
and Tilley 2007).
OA can affect any joint of the body though the weight-bearing joints, hip and knee, are often 
important sites for this disease. Aging is a major risk factor for the development of OA, the other risk 
factors are abnormal loading conditions due to trauma, heavy manual labour and obesity (Hamerman 
1993, Roach and Tilley 2007). In addition, genetic factors, e.g., a defect in type II collagen, may 
predispose to OA (Vikkula et al. 1993). A breakdown of the collagen fibril network is considered to be 
the critical and probably the irreversible step in the progression of OA (Eyre 2002).
Typical symptoms of OA are pain, joint stiffness and restriction of joint mobility. The clinical 
diagnosis of OA is based on the patient history and clinical examination of affected joints. Plain X-ray 
images are usually sufficient to confirm the diagnosis. Primary OA is a difficult disease for both the patient 
and the clinician, because often neither can any true cause be found nor any effective cure initiated. Once 
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the degenerative process has started, the disease cannot be halted and the only relief can be achieved by 
palliative treatment. This includes treatment with analgesics, intra-articular injections of corticosteroids 
or HA, physiotherapy and surgical interventions including osteotomies and eventually joint arthroplasty.
 Although OA is generally considered as a cartilage-related disease, it affects periarticular bone 
as well. The subchondral bone plate thickens during the OA process. It is still unclear whether these latter 
changes are causative or if they are a consequence of cartilage degradation (Roach and Tilley 2007). 
2.8 Animal models of experimental osteoarthrosis
Animal models provide one way to elucidate the early OA changes in vivo. Animal models allow 
accurate timing of the follow-up of changes occurring in the OA progress. An optimal animal model 
should reproduce both the pathogenesis and the pathology of human OA. Nonetheless the interpretations 
of disease pathogenesis needs to be made with caution when results from an animal model are extrapolated 
with the same disease in humans.
Some mouse strains develop spontaneous OA during their lifespan (Silberberg and Silberberg 
1941, Sokoloff 1956). The onset of degenerative cartilage changes can be accelerated by utilizing weight-
bearing or strenuous exercise regimens (Arokoski et al. 1993a, Lapveteläinen et al. 1995). In most 
species, however, the prevalence of spontaneous OA is too infrequent to be of value in experimental 
studies.
The development of transgenic technology has made it possible to generate targeted gene-mutated 
mouse lines suitable for use in experimental OA research (Helminen et al. 2002). The vast majority of 
these studies have focused on the effect of collagen mutations, but also the role of other matrix proteins 
in the pathogenesis has been studied (for review see Helminen et al. (2002)). In addition, studies using 
surgical interventions to provoke OA changes have been reported (Lovász et al. 1995, Panula et al. 1997, 
Pritzker 1994). 
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3 AIMS OF THE STUDY
The aims of the present study were to evaluate:
1. The effect of long-term running exercise on canine bone mineral density, me-
chanical properties and organization of collagen fibril network.
2. The effect of immobilization and remobilization on the canine bone mineral 
density, composition and bone structure.
3. The effect of osteotomy of the canine proximal tibia and the development of 
experimental osteoarthrosis on subchondral bone remodelling.
4. The impact of heterozygous knockout inactivation of one allele of the Col2a1 
gene on the bone development and properties.
5. The effect of the truncated human COL2A1 transgene on bone development and 
bone remodelling in mice.
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4 MATERIALS AND METHODS
4.1 Animal models
This study utilizes material from five animal studies carried out by the KUVANI1-team in the 
Department of Anatomy, University of Kuopio, Finland during years 1989–1995 (Table 2).
Table 2. Summary of the animals and study groups. HZK (heterozygous knock-out), TG (transgenic).
1KUVANI is an acronym for ”kuormituksen vaikutus nivelrustoon” (the effect of 
loading on articular cartilage)
Study
Number and (age) of the 
animals Study groups (gender and intervention)
I 10 (15-50 wk) female beagle dogs in progressive running training
(n=20) 10 (15-50 wk) female beagle dogs served as controls
8 (29-40 wk) female beagle dogs cast-immobilized (29-40 wk)
II 9 (29-90 wk) female beagle dogs cast-immobilized (29-40 wk) and remobilized (40-90 wk)
(n=34) 8 (29-40 wk) female beagle dogs served as controls
9 (29-90 wk) female beagle dogs served as controls
8 (12 wk - 7  mo) female beagle dogs with valgus osteotomy of proximal tibia
7 (12 wk - 18 mo) female beagle dogs with valgus osteotomy of proximal tibia
III 7 (12 wk - 7  mo) female beagle dogs with sham operation
(n=44) 7 (12 wk - 18 mo) female beagle dogs with sham operation
8 (12 wk - 7 mo) female beagle dogs served as controls
7 (12 wk - 18 mo) female beagle dogs served as controls
27 (4 wk - 15 mo) female HZK C57BL mice
22 (4 wk - 15 mo) female C57BL mice served as controls
IV 33 (4 wk - 15 mo) male HZK C57BL mice with running ability
(n=205) 30 (4 wk - 15 mo) male C57BL mice with running ability
31 (4 wk - 15 mo) male HZK C57BL mice served as controls
31 (4 wk - 15 mo) male C57BL mice served as controls
V 48 (1 wk - 12 wk) female TG FVB/N mice
(n=100) 52 (1 wk - 12 wk) female FVB/N mice served as controls
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4.1.1 Canine long-term running training (I)
 Twenty female purebred beagle dogs from the National Laboratory Animal Centre in Kuopio, 
Finland and from Shamrock Ltd., UK, were used as experimental animals. The experimental design was 
approved by the Animal Care and Use Committee of the University of Kuopio and it complied with the 
principles of the Care and Use of Animals (National Research Council 1985). Ten dogs ran five days a 
week according to a progressive program on a treadmill from the age of 15 weeks to the age of 70 weeks 
(Figure 6). During the first ten weeks of the training program, the dogs were adapted to running whereafter 
the running distance was gradually increased up to 40 km/day with the dogs running this distance, five 
days a week for the last 15 weeks of the experiment (Arokoski et al. 1991). The speed of the treadmill 
was 5.5–6.8 km/h and the inclination of the treadmill belt was 15 degrees uphill. Ten age-matched sister 
dogs were housed in individual cages during the study period. The bottom areas of the cages were 0.9 x 
1.2 m and the height 0.8 m. After exercise, the dogs rested in individual cages. During the rest period in 
the cage, the moving activity was recorded by the rest shelf method (Arokoski et al. 1993b). While in the 
cages, no statistically significant difference was detected between the moving activities of the exercised 
and control animals. The dogs were fed with a commercial dog food (Hankkija, Kolppi, Finland) and 
water was given ad libitum. The running dogs had three to four breaks for rest and drinking during each 
running bout. The individual amount of food to dogs was calculated by weekly weight monitoring to 
maintain the body weights at the same level in both groups. The food consumption of the runner dogs 
was approximately 1.5 times higher that of the controls during the last 15 weeks of the experiment.
Within 60 hour of completing the running regime, the dogs were sacrificed with an overdose 
of barbiturate (Mebunat, Orion Oy, Espoo, Finland) and their spines, femoral and pelvic bones, were 
immediately dissected free of soft tissue. Before sacrifice, X-ray radiographs were taken from the spines 
and the bones. Within 1.5 hours, all the samples were weighed, anthropometric measurements were 
recorded and the samples were fixed or frozen for further analyses.
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Figure 6. Running protocol. The dogs ran from the age of 15 weeks to the age of 70 weeks, 
five days a week. The daily running distance was gradually increased to the final distance of 
40 km/day.
4.1.2 Canine immobilization and remobilization (II)
Thirty-four female purebred beagle dogs obtained from Marshall Farms (North Rose, NY, 
USA) were used for this experiment. The dogs were kept in steel cages (0.9 x 1.2 x 0.8 m) in the 
National Laboratory Animal Centre of the University of Kuopio, Finland. The beagles were fed with 
commercial dog food (Hankkija, Kolppi, Finland) and water was given ad libitum. The dogs were treated 
in accordance with the principles given in the National Research Council’s Guide for the Care and Use 
of Laboratory Animals (National Research Council 1985). The Animal Care and Use Committee of the 
University of Kuopio approved the design of this experiment.
The right hind limbs of seventeen dogs were immobilized in 90° flexion of the knee joint with a 
fibreglass cast (Dynacast Pro, Smith and Nephew Medical, Hull, UK) (Haapala et al. 2000, Haapala et 
al. 1999). The immobilized foot was tied to the body of the dog to prevent loading. The cast was applied 
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at the age of 29 weeks for an 11-week period of experiment. At the age of 40 weeks, eight dogs were 
killed using an overdose of pentobarbital (Mebunat, Orion Oy, Espoo, Finland), and nine dogs were 
remobilized. The remobilization period lasted 50 weeks. The dogs ambulated freely in their cages. Age-
matched littermate dogs formed the control group for the immobilized and remobilized dogs. After the 
experiment, bone samples were collected and freed from soft-tissue and thereafter frozen at -20 °C for 
further analyses.
4.1.3 Canine osteotomy of proximal tibia (III)
Forty-four female beagle dogs of pure breed were purchased from Marshall Farms (North Rose, 
NY, USA) consisting of 14 sister triplets and one sister twins. Littermate dogs were divided into six 
experimental groups. The experimental groups included valgus osteotomy -group, sham operated and 
control group with two time points, 7 months and 18 months after the operation (Panula et al. 1997). 
A 30° valgus angulation of the right tibia was achieved by surgical operation in 15 dogs at the age of 
three months. Fourteen littermate dogs were sham operated (tibia and fibula were osteotomized without 
angulation) and fifteen sister dogs served as controls. The dogs were fed with commercial dog food 
(Vaasan Mylly Oy, Vaasa, Finland) 240 g per day. Water was given ad libitum. During the experiment, the 
dogs were kept under kennel conditions in the National Laboratory Animal Center (Karttula, Finland). 
The Animal Care and Use Committee of the University of Kuopio approved the experimental design. 
The experimental protocol complied with the principles of the National Research Council’s Guide for 
the Care and Use of Laboratory Animals (National Research Council 1985).
The surgical procedure of valgus osteotomy of proximal tibia was described in detail in a previous 
report (Panula et al. 1997). The osteotomy line was carried out 10–12 mm distal to the growth plate of 
proximal tibia in the direction of the tibial plateau. Through a separate skin incision, 5 mm of the fibular 
bone was excised at its upper third to allow the tibial osteotomy surfaces to come in contact with each 
other. The osteotomy was fixed using a prebent 30° T-shaped AO plate (Stratec Medical, Waldenburg, 
Switzerland) on the medial aspect of the tibia with screws.
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The operated dogs received benzylpenicillin and streptomycin antibiotics intramuscularly for 
2 days after the operation. Buprenorphine was used as the postoperative analgesic. No cast was used 
and the dogs were allowed to use the operated limb immediately after recovery from the anaesthesia. 
During the first week after operation, the dogs gradually increased weight-bearing and after four weeks 
no limping could be observed. Dogs with 30° valgus osteotomy showed a slight external rotation of the 
operated limb when standing. This was not observed in the sham-operated dogs.
After euthanasia with an overdose of anaesthetic, the hindlimbs were dissected free from soft 
tissues. The stability of the osteotomy line was examined after AO plate removal. The bones including 
femurs and tibiae were frozen at -20 °C for further analyses.
4.1.4 Murine heterozygous knockout inactivation of one allele of the Col2a1 gene (IV)
In this experiment, two genetically different inbred mouse lines were investigated. Conventional 
C57BL/6JO1aHsd breeders were obtained from Harlan CBP (Rijswijk, The Netherlands) and knockout 
breeders, C57BL/6-TGN (Col2a1 heterozygous knockout) originated from the laboratory Animal 
Services of Thomas Jefferson University (Philadelphia, PA, USA). The knockout breeders were 
produced using a homologous recombination technique (Li et al. 1995). Breeding and the experiment 
took place in the National Laboratory Animal Centre (Kuopio, Finland). Breeders heterozygous (HZ) 
for the Col2a1 allele, one allele inactivated, were mated with normal C57BL/6JO1aHsd breeders to 
obtain either normal or heterozygous pups. The genotype was verified using polymerase chain reaction 
(PCR) from the samples taken at the age of three days (toe tips) and, for confirmation, at the age of three 
weeks (tail tips). The missing toe tips served also as identification codes. After weaning at the age of 
three weeks, the pups lived with their littermates for one week and were then placed in individual cages 
at the age of one month. The dimensions of the polycarbonate cages were 16 cm x 32 cm (512 cm2) 
floor area and 12.5 cm height. The cages were equipped with steel wire lids. Cages of the runner mice 
had also stainless steel running wheels, 8 cm wide and 23 cm of inner diameter. The runner mice could 
access freely the running wheels 24 hours a day. A sensor and information storage system was used to 
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record the movements of the running wheels (Lapveteläinen et al. 1997). Cages and running wheels 
were commercially available (Techniplast Cazzada SARL., Varese, Italy). The room temperature was 
kept between 19 and 23 °C, humidity 30–70%, ventilation rate 7–18 times per hour, noise levels 40–55 
dB (20–50000 Hz), and the light cycle 12 hours light and 12 hours dark. Commercial R36 mouse food 
(Lactamin Ab, Stockholm, Sweden) was given and tap water were available ad libitum.
From the HZ Col2a1-knockouts and controls, the following experimental groups were formed: 
normal controls, normal runners, HZ knockout controls and HZ knockout runners. The groups of mice 
were sacrificed at two time points; the first at the age of 9 months (average group size 20 mice) and 
the second at the age of 15 months (average group size 15 mice). The consumptions of food and water 
as well as the weight development were recorded weekly. After the first time point, only the weight 
development was recorded at monthly intervals.
4.1.5 Transgenic mice harbouring truncated human COL2A1 gene (V)
In this study we utilized transgenic (TG) mice, which were generated using the human type II 
procollagen construct described by Vandenberg et al. (Vandenberg et al. 1991) and Helminen et al. 
(Helminen et al. 1993). The mice harboured a 291 codon-long deletion mutation in the COL2A1 transgene 
of human collagen type II. This caused a deletion of 12 exons of the 54 exons of the gene. Therefore, the 
internally deleted gene construct coded for a shortened proα1(II) chain with an in-frame deletion of 291 
amino acids (α1-157 to 447) of the 1,014-residue-long triple-helical domain. The transgenic mice were 
generated and propagated in the inbred FVB/N strain.
A total number of 100 female mice were used: 48 TG and 52 control littermates (wild-type) mice, 
obtained from the Thomas Jefferson University, Jefferson Medical College, PA, USA, were utilized. 
They were divided into three age groups, to be analyzed at the age of one week, one month and three 
months.
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4.2 Methods
4.2.1 Bone densitometry
4.2.1.1 DXA (I-IV)
For canine studies (I-III), Lunar DPX bone scanner (Lunar Corp., Madison, WI, U.S.A.) was 
utilized to determine the BMD of thoracic (segments C2-4) and lumbar spine (segments L6-7), iliac, 
third metatarsal and radius bones (I). Left and right proximal femurs were also measured (II and III). 
Two X-ray energies were used in the DXA analysis (38 keV and 70 keV). Prepared bones were dissected 
free of surrounding soft tissue and frozen at -80 °C prior to the measurement. The scanner was calibrated 
according to the operator’s manual provided by the manufacturer. The samples were positioned in a 
plastic container filled with water to simulate soft tissue density. The depth of the water layer was 12 cm 
with canine samples and 2 cm with murine samples. All measurements were performed in triplicate and 
the mean value of the measurements was recorded.
The BMD of the mice (IV) was determined using the second generation Lunar Expert (Lunar 
Corp., Madison, WI, U.S.A.) DXA-scanner. The densitometer was calibrated with a bone phantom every 
4 hours according to the guidelines provided by the manufacturer. The results were expressed in grams 
(g) per square centimetre (cm2).
4.2.1.2 QCT and pQCT (I, IV)
Trabecular BMD (I) was measured using a Siemens DR 1 QCT-scanner (Siemens AG, Karlsruhe, 
Germany). The consecutive slices of 4 mm thickness were scanned with energy of 96 kV, 300 mA. For 
calibration, phantoms of known density (KMnO
4
, H
2
O, and air) were also scanned. The correction of 
density measurement was calculated using water (set as 0 Hounsfield units (HU)) and air (set as -1000 
HU) phantoms in the equation:
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   (9)
in which HU
b
 represents the bone density, HU
w
 and HUa are the measured densities of water and 
air phantoms, respectively. The density of a predetermined ROI was presented as the corrected HU. For 
bone, the measured densities are usually over +400 HU.
 In study IV, a Stratec 960A pQCT scanner was used (Norland Stratec Medizintechnik GmbH, 
Birkenfeld, Germany). The femurs were aligned axially with the anterior surface upward in a custom-
made sample holder. The exact mid-point of the diaphyseal segment was ensured using the scout view. 
Mean volumetric BMD, CSMI, mean cortical thickness, periosteal and endosteal circumferences were 
determined using the pQCT analyzing software at an attenuation threshold value of 0.815 cm-1. Routine 
calibration of the system was performed daily with a phantom sample provided by the manufacturer. 
4.2.2 Bone mechanical testing (I, IV)
Biomechanical parameters of canine trabecular bone were estimated by using the compression 
test (I). The test was performed using two standard locations in vertebral trabecular bone and three 
locations in iliac bone (Figure 1, I). The material test apparatus and the measurement settings have been 
described earlier (Räsänen et al. 1991). For the testing, a cylindrical plane-ended indenter, with a contact 
area of 3.02 mm2, was employed. After the indenter was adjusted to come into contact with the sample 
surface, a compression test was performed using an indenter speed of 0.166 mm/s, until the fracture 
threshold was achieved. The diameter of the indenter covered up several trabeculae of the specimen.
The bending strength of mice femora (IV) was determined by the three-point bending test. The 
testing device was described earlier (Jämsä et al. 1996). The whole bone samples were set on two fulcra 
lying 6.5 mm apart from each other. The indenter head as well as the two fulcra were rounded to avoid 
shear load and cutting of the bone during the test. The loading force was directed vertically to midshaft 
of the bone. The compression continued at constant speed of 0.155 mm/s until failure.
€ 
HU = 1000(HUb − HUw )HUw − HUa
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The load-time curves were recorded using a standard x-y plotter (IV) or a custom-made software 
application (I). The plotter curves were digitized, converted to force-deformation curves and analyzed 
using an image analysis software (UTHCA ImageTools for Windows v.1.28, University of Texas Health 
Science Center, San Antonio, TX, U.S.A.). The stress, strain and elastic modulus (Young’s modulus) 
were calculated as follows (Turner and Burr 1993):
   (10)
    
   (11)
      
    (12),
where σ is stress, ε is strain, c is the distance from the center of mass, F is applied force and L is the 
distance between the fulcra in the three-point bending test. I refers to the CSMI determined by pQCT. 
The stiffness of the sample was determined from the slope of the force-deformation curve at its elastic 
region (Figure 5).
4.2.3 Quantitative X-ray imaging (I, IV-V)
 X-ray images of the vertebral column, forefoot and hind limb in canine studies (I-III) were taken 
after the experiment. The measurements were performed using a scaling device at a transillumination 
board.
Total body X-ray images were taken from the mice in studies IV and V. The standard anterior-
posterior and lateral images were taken with 50 kV tube voltage (15mAs). The images were digitized 
at 600 dpi (dots per inch) resolution using a computer equipped with a scanner (Microtek international 
Inc., Düsseldorf, Germany). The anthropometric parameters including individual bone length and width 
were measured with Prism (Analytical Vision Inc., Raleigh, NC, U.S.A.) and NIH Image v.1.62 (NIH, 
€ 
σ =
FLc
4I
€ 
ε =
12cd
L2
€ 
E = FL
3
d48I
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Bethesda, MD, U.S.A.) image analysis software.
4.2.4 Bone histomorphometry (I-III, V)
Static (I-III) and dynamic (V) histomorphometry was performed using a semiautomatic 
Kontron Osteoplan II image analysis system (Kontron GmbH, Munich, Germany) with Zeiss Axioskop 
microscope (Zeiss, Thornwood, NY, U.S.A.). The bone samples were dissected free of soft tissue, and 
fixed in 70% ethanol. After dehydration in graded alcohol solutions, the specimens were embedded in 
methyl methacrylate. Sections of 5 to 7 μm in thickness were cut using a Reichert- Jung K polycut S 
microtome with HK knives (Jung, Heidelberg, Germany). After dissolving the methyl methacrylate, the 
sections were stained with modified Masson-Goldner trichrome stain. For dynamic histomorphometry, 
fluorescent double labelling with calcein was performed by intraperitoneal administration of the agent 
five and two days before sacrifice. The following data were collected: trabecular bone volume fraction 
(BV/TV), trabecular thickness (Tb.Th), trabecular separation (Tb.Sp), trabecular number (Tb.N), percent 
osteoid volume (OV/BV), specific osteoid surface (OS/BV), percent osteoid surface (OS/BS), osteoid 
thickness (O.Th), percent eroded surface (ES/BS), specific eroded surface (ES/BV), erosion depth 
(E.De), percent osteoid to eroded surface (OS/ES), osteoblast number (N.Ob/B.Le), osteoclast number 
(N.Oc/B.Le). In dynamic bone histomorphometry, additional parameters including mineral apposition 
rate (MAR) and bone formation rate (BFR/BV) were calculated.
4.2.5 Quantitative polarized light microscopy (PLM) (I, IV)
Quantitative polarized light microscopy was used to estimate the spatial arrangement and 
organization of collagen fibrils in bone (Király et al. 1997). Five-μm-thick sections were cut from 
decalcified bone samples. After deparaffinization, the PGs were removed with testicular hyaluronidase 
digestion. The unstained sections were analyzed with a Leitz Ortholux II Pol BK2 microscope (Leitz, 
Wezlar, Germany) using a 16/0.45 N.A. strain free objective. For PLM analysis, light with the wavelength 
of 591.4 nm was used and adjusted by a monochromator filter (IL 591.4 nm, t 1/2–width 19.3 nm; Schott, 
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Iserlohn, Germany). Digital images were taken for the birefringence analysis using a Photometrics CH-
250 CCD-camera (Photometrics, Tuscon, AZ, U.S.A.). The ROI was selected randomly by rotating the 
stage of the microscope where the section was placed. Values for birefringence were determined as a 
mean of the filtered light intensity (area-adjusted integrated retardation value of polarized light, AIR). 
The measurements were performed twice and the mean values were used for calculation.
4.2.6 Elemental composition of bone samples (I, II)
The second thoracic vertebral body, a standard region of frontal bone and the proximal head of 
the ulnar bone in study I, and a standard region of trochanter major in study II were assayed for their 
elemental composition, carbonate and citrate. The bones were macerated in chloroform-methanol (2:1) 
to remove fat. The samples were dried at 105 °C and pulverized. Citrate was released with 2 M H
2
SO
4
 
for 1 h at +60 °C and the samples were analyzed after neutralization using a commercial kit (Boehringer 
Mannheim, cat. no. 139076, Mannheim, Germany). Fifty mg of the bone sample was ashed at +500 °C 
for 10 h. After ashing, samples were dissolved 4x250 μl 3 M HNO
3
 and diluted to 10 ml. Ca, Mg, Zn, 
K, and Na were determined by atomic absorption spectrophotometry (Perkin Elmer model 372, Perkin 
Elmer Corp., Norwalk, CT, USA). Perkin Elmer Intensitron hollow cathode lamps were used and the 
operating parameters in the linear working range were followed as described in the manufacturer’s 
operating manual. The reproducibility in the Ca and Zn determinations was within 2%. The recovery 
rates varied from 99.1% to 99.7%.
4.2.7 Statistical analyses (I-V)
Data distributions for each parameter in this study are expressed as mean ± standard error of the 
mean (SE) or SD. Non-parametric Wilcoxon matched-pairs signed-ranks test and the two-tailed Mann-
Whitney U-test were used to calculate statistical significance of differences between the experimental 
and control groups (I-III). The Mann-Whitney U-test was also used in studies with mice (IV-V), because 
the normal distribution of the data could not be assumed on account of the relatively small sample size. 
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PLM results were tested using the Kolmogorov-Smirnov test, which is more sensitive to differences 
in the general shapes of the data distributions between two samples. Pearson’s correlation coefficient 
was calculated to evaluate the correlation between the biomechanical properties and the anthropometric 
parameters in study IV. Various versions of statistical software package (SPSS for Windows, SPSS Inc, 
Chicago, IL, U.S.A.) were used in calculation. P values less than 0.05 were considered statistically 
significant.
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5 RESULTS
5.1 Effect of long-term training on canine bone (I)
All dogs were able to complete the training regimen and the physical condition of the animals 
remained good throughout the study. The growth plates of the long bones had closed by the end of 
the study period in both groups. The X-rays of spines and extremities were normal in all animals. The 
weight-bearing bones were larger while the vertebrae were smaller in the runner dogs as compared with 
the controls (Table 3).
Table 3. Anthropometric measurements (mean ± SE).
Parameter Controls (n=10) Runners (n=10)
Weight
Body (kg) 12.4 ± 0.3 12.3 ± 0.3
Radius bone (g) 12.8 ± 0.4 14.4 ± 0.6
Radius bone/body wt (g/kg) 1.05 ± 0.02 1.17 ± 0.04 *
Ulnar bone (g) 14.4 ± 0.3 15.5 ± 0.6
Ulnar bone/body wt (g/kg) 1.16 ± 0.03 1.26 ± 0.04 *
Hip bone (hemipelvis) 37.5 ± 1.9 39.0 ± 2.6
Th 2 vertebra 2.47 ± 0.10 2.45 ± 0.12
Length (cm)
Radius 11.5 ± 0.2 12.0 ± 0.5
Ulna 13.9 ± 0.3 14.4 ± 0.2
Height (mm)
Th 2 14.3 ± 0.28 14.1 ± 0.28
Th 3 14.0 ± 0.32 13.7 ± 0.26
Th 4 14.0 ± 0.28 13.7 ± 0.15
Radius diaphysis
Cross-sectional area (cm2) 0.90 ± 0.03 0.96 ± 0.03
Cortical bone area (cm2) 0.67 ± 0.01 0.72 ± 0.02
Cortical index (%) 74.63 ± 1.71 74.56 ± 1.57
* p < 0.05 between runners and controls
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The density distribution of vertebral bodies differed between the runners and the controls (Figure 
7). The shapes of the curves in mid-frontal and mid-sagittal planes were similar in both groups in thoracic 
and lumbar spines. Higher bone densities were observed in cortices and posterior parts of the vertebral 
segments. The BMDs were significantly lower in thoracic and lumbar spine, ilium, radius and MT III in 
the runner dogs as compared with their littermate sisters (Figure 8). 
Interestingly, the biomechanical properties of trabecular bone of vertebrae or iliac bone revealed 
no differences between the study groups. However, the ultimate fracture force needed to break the 
vertebral bodies was lower (p < 0.05) than that of iliac crest in the runner dogs (Figure 9).  
Zinc and sodium accumulated in the bones of the trained animals (Table 4). BMDs correlated 
significantly with bone ash weight ( r= 0.62, p < 0.01) and zinc content (r = -0.54, p < 0.05), but not 
with calcium concentration (r = 0.30). The amount of urinary calcium and the concentration of serum 
alkaline phosphatase were significantly higher in the exercised group (Table 5).  Other markers of bone 
metabolism did not show any differences between groups. Serum estradiol levels were lower in the 
runner dogs at the age of 55 weeks.
Thoracic vertebra 2 Ulnar bone Frontal bone
Controls 
(n=10)
Runners 
(n=10)
Controls 
(n=10)
Runners 
(n=10)
Controls 
(n=10)
Runners 
(n=10)
Dry wt/ash wt 1.97 ± 0.039 1.91 ± 0.036 1.60 ± 0.013 1.57 ± 0.007 1.56 ± 0.012 1.56 ± 0.018
Ca/dry wt (mg/g) 167 ± 3 164 ± 4 170 ± 3 160 ± 4 215 ± 3 213 ± 2
Ca/ash wt (mg/g) 319 ± 2 322 ± 3 303 ± 3 309 ± 4 336 ± 3 332 ± 2
Mg/ash wt (mg/g) 5.90 ± 0.07 5.84 ± 0.07 5.27 ± 0.03 5.18 ± 0.05 5.28 ± 0.06 5.33 ± 0.07
K/ash wt (mg/g) 5.73 ± 0.3 5.92 ± 0.1 6.91 ± 0.3 8.47 ± 0.6 * 4.86 ± 0.2 4.78 ± 0.2
Na/ash wt (mg/g) 10.2 ± 0.15 11.5 ± 0.27 ** 8.8 ± 0.09 9.3 ± 0.14 * 9.6 ± 0.14 9.2 ± 0.06 **
Zn/ash wt (mg/g) 0.23 ± 0.007 0.26 ± 0.007 ** 0.19 ± 0.008 0.22 ± 0.009 * 0.16 ± 0.005 0.18 ± 0.005 *
F/ash wt (mg/g) 0.22 ± 0.005 0.22 ± 0.001 0.17 ± 0.004 0.17 ± 0.001 0.15 ± 0.006 0.14 ± 0.006
Citrate/dry wt (μg/g) 7.4 ± 0.27 7.5 ± 0.23 9.5 ± 0.37 9.5 ± 0.44 6.9 ± 0.41 8.7 ± 0.31 *
Carbonate (μg/g) 33.1 ± 0.7 31.2 ± 0.6 38.7 ± 0.7 34.5 ± 0.7 46.1 ± 0.9 46.5 ± 0.7
*p < 0.05, **p < 0.01 between controls and runners (Wilcoxon matched-pairs signed-ranks test).
Table 4.  Elemental composition of bones (mean ± SE)
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Figure 7. The density distribution in thoracic and lumbar vertebrae measured from consecutive QCT 
sections data at the mid-frontal and mid-sagittal planes at right angles to each other (shown in picture). 
The values are expressed in adjusted Hounsfield’s units (HU) with standard gray-scale windowing of 
the actual HUs, in which +500 HU equals the adjusted value of 255 an 0 HU equals to value 0.  The 
lengths of the planes were adjusted to be comparable with each other (percentage scale of the plane). 
Kolmogorov-Smirnov test was used to test the similarity of the density distributions. ***p < 0.001.
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Figure 8. Comparison of bone mineral density in thoracic (Th) and lumbar (L) spine, radius, ulna, third 
metatarsal (MT III) and iliac bone. The runner values are given as percentage difference (mean ± SE) 
compared with their littermate sisters. The measurements were carried out with quantitative computed 
tomography (QCT) and dual-energy x-ray absorptiometry (DXA). *p < 0.05, **p < 0.01.
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There were no differences in bone histomorphometry (Table 3, I) or in the concentration of 
collagen crosslinks (Table 2, I). However, quantitative PLM showed higher organization of the collagen 
matrix in the trabecular bone of the vertebral bodies (Figure 2, I)
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Figure 9. Ultimate stress at fracture of canine trabecular bones of the lumbar vertebra and the iliac crest 
of runners and age-matched controls at the age of 70 weeks. Mean ± SEM. Wilcoxon matched pairs 
signed ranks test. *p < 0.05.  
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Table 5. Serum and urine calcium, serum alkaline phosphatase (S-ALP), serum estradiol, osteocalcin (S-
OC), carboxyterminal propeptide of type I procollagen (S-PICP) and cortisol in the beginning and at the 
end of the 40 km/day exercise period, i.e. at 55 and 70 weeks). Modified from Puustjärvi et al. (1995). 
Parameter Runners (n=10) Controls (n=10)
mean ± SEM mean ± SEM
S-Ca (mmol/l)
55 weeks 2.66 ± 0.03 2.74 ± 0.04
70 weeks 2.55 ± 0.03 2.54 ± 0.03
U-Ca (mmol/day)
55 weeks 0.67 ± 0.08 0.39 ± 0.08
70 weeks 1.21 ± 0.10 0.79 ± 0.12
S-ALP (U/l)
55 weeks 236.6 ± 22.5** 109.7 ± 7.7
70 weeks 123.7 ± 8.7** 86.6 ± 9.2
S-estradiol (nmol/l)
55 weeks 0.021 ± 0.003* 0.036 ± 0.009
70 weeks 0.022 ± 0.004 0.027 ± 0.006
S-OC (ng/ml)
55 weeks 0.29 ± 0.02 0.36 ± 0.03
70 weeks 0.58 ± 0.07 0.64 ± 0.07
S-PICP (μg/l)
55 weeks 5.3 ± 0.5 5.3 ± 0.5
70 weeks 7.7 ± 1.5 6.4 ± 0.8
S-Cortisol (nmol/l)
55 weeks 6.3 ± 1.0 5.0 ± 1.5
70 weeks 5.4 ± 1.6 6.8 ± 1.7
*p < 0.05 and **p < 0.01. 
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5.2 Effects of immobilization and remobilization on canine bone (II)
After casting of the lower limb, the dogs soon ambulated actively in their cages. Splinting did 
not reduce the range of motion of the knee joint. One week after the remobilization, the gait of the 
remobilized dogs appeared similar to that of controls (Haapala et al. 2000). There were no changes in 
overall growth or weight between the groups (Table 6). The cast-immobilization for a period of 11 weeks 
caused a significant site-dependent 21.8–27.4% bone loss in the casted proximal femur (p < 0.01) and 
also systemic 4.7–10.9% decrease of BMD in the contralateral limb (Table 3, II) in comparison with the 
age-matched controls. These changes had recovered after the remobilization period of 50 weeks.
Table 6. The weight (kg ± SD) of dogs at the beginning of the immobilization (29 weeks), 
at the beginning of the remobilization (40 weeks), and at the end of the remobilization 
period (90 weeks).
Age (weeks)
29 40 90
Immobilized (n=8) 9.8 ± 1.8 10.2 ± 2.1
Controls (n=8) 9.7 ± 1.7 10.1 ± 1.9
Remobilized (n=9) 8.9 ± 1.9 9.2 ± 1.4 10.1 ± 2.1
Controls (n=9) 9.1 ± 1.2 9.3 ± 1.3 9.8 ± 1.6
Immobilization induced accumulation of zinc not only in the splinted limb but also on the 
opposite side (p < 0.05). However, the changes became normalized after remobilization. The calcium 
concentration was 9.3% lower in immobilized bone than in the contralateral weight-bearing bone (p 
< 0.05). After the remobilization period of 50 weeks, there were no differences in immobilized and 
weight-bearing bones with regard to the concentrations of calcium, phosphorus, sodium and zinc (Table 
2, II). There was a positive correlation between BMD and bone calcium content (r = 0.453, p < 0.001) 
and Ca/P-ratio (r = 0.461, p < 0.001), while bone phosphorus, sodium and zinc concentrations showed 
a negative correlation with BMD (r = -0.466, p < 0.001; r = -0.324, p < 0.01 and r = -0.263, p < 0.05, 
respectively). The calcium concentration of bone correlated negatively with sodium (r = -0.610, p < 
0.001) and zinc (r = -0.353, p < 0.01) contents.
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Bone histomorphometry revealed osteopenia in the bones of splinted dogs. The bone volume (BV/
TV) was 21.1% lower and the trabecular separation was 8.3% wider in the immobilized bone as compared 
with the bone of the contralateral limb (Table 4, II). Bone turnover was increased in the immobilized 
bone, since bone formation and resorption had both increased when compared with the weight-bearing 
bone of the opposite side. Remobilization reversed the immobilization induced osteopenic changes in 
bone histomorphometry.
5.3 Effects of proximal tibial osteotomy on canine bone (III)
The BMD of the proximal femur decreased in the right (operated) limb after osteotomy as 
compared with the contralateral limb of age-matched controls (Figure 10). At the same time, the BMD of 
the contralateral limb increased as compared with the controls. Most changes at 7 months after operation 
were seen in the proximal part of the femur, in the caput and collum, where the percentage of the 
trabecular bone is greatest. The decrease of BMD was seen later (18 months after the operation) also 
in the metaphyseal and diaphyseal ROIs, where the rate of bone turnover is somewhat lower. Similar 
changes in all ROIs were seen in the sham-operated dogs, although to a lesser extent.
Data about the structure and turnover of subchondral bone are presented in Table 1 (III). The 
differences of bone structure parameters between operated and control dogs did not reach statistical 
significance except for the number of trabeculae (Tb.N) in the medial femoral condyle, where the number 
decreased in the operated animals as compared to controls (p < 0.05). This was associated with a non-
significant decrease in the bone volume (BV/TV). Most changes in the femoral bone histomorphometry 
were seen in the subchondral region of patellar surface, where the osteoid thickness (O.Th), osteoblast 
surface/bone surface (OS/BS), erosion depth (E.De) and active erosion depth (E.De[Oc+]) indicated 
increased bone remodelling in subchondral bone in the operated animals as compared with the controls 
(p < 0.05). 
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Figure 10. Bone mineral density measurements determined by dual-energy X-ray absorptiometry from 
caput, collum, metaphysis and diaphysis of femur at the age of 7 (left triplets) and 18 months (right 
triplets) after osteotomy. Wilcoxon matched-pairs signed-ranks test. *p < 0.05.
5.4 Effects of heterozygous knockout of one allele of the Col2a1 gene on murine 
bone (IV)
 The overall phenotype appearance of the HZ knockout (HZK) and wild-type (wt) mice was 
similar. The body weights of the normal runners were 2–10% lower than those of the controls (p < 0.01 
at the age of six months). No differences were seen in the lengths of the body or tail. The female mice 
had to some extent longer and narrower femurs as measured from X-ray images (Sahlman et al. 2001).
The daily running distance increased continuously during the first three months in HZK and wt 
runners in conjunction with the size of the mice. There was a marked difference in the running activity, 
speed and cumulative running distance in HZK mice as compared with the wt runners (Figure 1, IV) 
indicating that the HZK mice were less willing to run. The difference was greatest from the age of 9 to 
11 months (p < 0.001). The average running speed was 6.9% lower in the HZK mice as compared with 
7 months 18 months
7 months 18 months7 months 18 months
7 months 18 months
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their wt controls. The HZK runners spent 114 hours less in the running wheel during the 9 months as 
compared with wt runners (p < 0.05). A remarkable decline in daily running activity was seen after the 
age of 4 months in both groups. The overall running activity took place at the dark hours of the day as 
would be expected from typical murine behaviour.
DXA showed 6.1% lower BMD in the male transgenic runners than in the group of normal 
runners at the age of 9 months (p < 0.05). The measured BMD was higher in the normal male runners as 
compared with their normal (non-runner) controls (p < 0.01), whereas there were no differences between 
the HZK runners and HZK controls (Table 1a and 1b, IV).    
The pQCT-results reflected the changes of DXA, even though they measured primarily the cortical 
bone densitiy (Table 1a and 1b, IV). The maximal breaking forces were 14.8% and 23.5% lower at the 
age of 9 and 15 months in the HZK male runners as compared with the control male runners (p < 0.05 
and p < 0.01, respectively). The breaking forces were 12.6% and 12.1% higher in the group of wt male 
runners at the age of 9 and 15 months than the corresponding values in the sedentary male wt controls (p 
< 0.05 and p < 0.01, respectively). This adaptation to an increased mechanical load was not seen in the 
HZK mice (Figure 2, IV). Anthropometric parameters seemed to reflect better the mechanical properties 
of bone than the density measurements (Table 2, IV). However, if the HZK mice are omitted from the 
analysis, the BMD measured using DXA correlated well with the breaking force (r = 0.419, p < 0.001).
Quantitative PLM revealed a 13.9% reduced degree of organization of the bone collagen fibril 
network in HZK runners than in the wt runners at the age of 9 months (p < 0.05, Figure 3, IV). This 
difference could not be observed anymore at the age of 15 months. Aging from 9 to 15 months decreased 
the AIR values of the normal runners by 46%, and 37% of the normal controls. Similar changes in AIR 
values were also seen in the HZK mice (32% and 28%, respectively).
The HPLC analyses of bone collagen did not detect any significant differences between the study 
groups in total collagen amount or in the crosslinking of the collagen fibrils (Table 3, IV).
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5.5 Effects of human COL2A1 transgene on murine bone (V)
TG mice carrying an internally deleted human type II collagen gene (COL2A1) were smaller in 
terms of weight and body size at the end of 3-month-long observation period (Figure 11, Figure 1 and 
Table 1, V). The cortical bone area of TG mice was thinner than that of the wt controls (p < 0.05, Figure 
12). The human type II collagen was actively expressed in the mouse tissues (Figure 2, V).
Dynamic bone histomorphometry revealed a nearly two-fold increase of the trabecular bone 
volume in the wt mice from the age of 1 week to the age of 3 months (Figure 4 and 5, V). The mean 
trabecular thickness increased concurrently by almost three-fold. No normal bone maturation process 
was seen in the TG mice, and the bone mass remained almost unchanged during the weeks of bone 
maturation leading to a difference of 47% in trabecular bone volume (p = 0.012) and 40% in trabecular 
thickness (p < 0.01) at the age of three months as compared with the control mice. The osteoid volume 
was lower in the TG mice than in the wt controls at the age of one week and one month, but the difference 
was not statistically significant. Bone erosion was greater at each time interval in the transgenic mice 
(Figure 5, V). At the age of three months, the specific eroded surface per bone volume (ES/BV) was 31% 
greater in the TG mice as compared with the wt littermates (p < 0.05).
A normal remodelling pattern and bone matrix mineralization was seen in both groups at all 
age intervals. At the two youngest age points, the mice in both groups produced proportionally more 
woven bone as compared with the pattern at the age of three months (p < 0.001). The qualitative analysis 
revealed that the production of woven bone was more pronounced in the TG mice. The collagen network 
in woven bone is immature and loosely organized. In contrast, normal lamellar bone contains highly 
organized collagen fibers in a parallel manner when analyzed using PLM. 
The trabecular thickness correlated positively with the body weight (r = 0.71, p < 0.001). 
Interestingly, the body weight correlated with bone volume in the wt mice (r = 0.27, p < 0.01) but 
no correlation was observed in the TG mice. Trabecular thickness decreased and trabecular separation 
increased at the age of 3 months in TG mice as compared with the age-matched wt controls. The femoral 
bones of the TG mice were weaker in the three-point bending test (Table 7).
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Table 7. Selected bone properties of three-month-old female mice.
3 months
Control (n=8-17) Transgenic (n=7-14)
Mean ± SD Mean ± SD
FEMUR - whole
Wet weight (mg) 58.9 ± 1.5 49.9 ± 1.6 ***
Wet weight/10 g body weight (mg) 26.2 ± 1.5 24.9 ± 1.8
Ash weight (mg) 22.7 ± 1.3 18.3 ± 0.9 ***
Ash weight/10 g body weight (mg) 10.1 ± 0.8 9.1 ± 0.6 **
Ash weight/bone weight (%) 39.2 ± 2.8 38.2 ± 3.5
FEMUR - diaphysis
Breaking force (N) 15.5 ± 0.7 14.4 ± 1.0
Displacement at break (mm) 0.75 ± 0.11 0.62 ± 0.05 ***
Bone Siffness (x103 N/m) 70.0 ± 8.2 64.5 ± 23.9
Energy for bone break (x10-3 Nm) 8.2 ± 1.3 6.1 ± 0.3 ***
HUMERUS - whole
Weight (mg) 31.6 ± 1.5 24.1 ± 1.0 ***
Weight/10 g body weight (mg) 14.1 ± 0.9 11.8 ± 1.1 ***
Ash weight/10 g body weight (mg) 6.1 ± 0.4 5.3 ± 0.4 **
Ash weight/bone weight (%) 43.6 ± 2.1 44.2 ± 1.7
*p < 0.05, **p < 0.01, ***p < 0.001 Transgenic vs. Control.
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Figure 11. Newborn pups (a) and three-month-old mice (b). Transgenic mice harbouring internally 
deleted human type II collagen gene COL2A1 (above) are smaller than their age-matched wild-type 
mice (below). Scale (cm).
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Figure 12. Diameter, cortical bone area and thickness values from femoral diaphysis of three-month-
old female mice determined after the three-point bending test. “Load” indicates direction of the 
indenter in relation to bone during three-point bending test.
Wild type Transgenic 
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6 DISCUSSION
The main objective of this study was to characterize the quality and mechanical strength of 
bone subjected to loading and unloading. On the other hand, the effects of defective type II collagen 
expression on mechanical loading of bone were studied using normal and transgenic animal models 
harbouring altered type II collagen genes. Animal models are one way to reliably control the loading 
effects of physical exercise or immobilization on bone. The material used in this study was a spin-off 
from a research line focusing on the development and prevention of OA at the Department of Anatomy, 
Institute of Biomedicine, University of Kuopio. In this study, we predefined that the material would 
consist of bone tissue, not cartilage, and we did not attempt to study the effects of various medical agents 
on bone metabolism.
OP and OA are two major and increasing health problems in the industrialized countries. The 
diseases lead to pain and loss of ability to work and function in everyday life. Although bone loss is 
a systemic condition in the skeleton in OP, the most frequent fractures occur at the hips, vertebrae, 
shoulder and distal forearms. If one considers all osteoporotic fractures, then the hip fractures are the 
most common cause of mortality and morbidity; 12—20% of hip fracture victims die within the first year 
of the fracture event and more than 50% of the survivors will be incapacitated (Consensus Development 
Conference 1991, 1993). Our possibilities for preventing bone loss and fractures are limited. In order to 
develop more effective treatment modalities, we need more information about the pathophysiology and 
pathogenesis of the diseases.
6.1 Effect of functional loading on bone (I)
The positive effects of physical training are well documented. However, strenuous long-
term exercise may evoke adverse effects on the skeleton, as we have reported here. In study I, long-
term strenuous exercise had a negative effect on BMD of the axial skeleton while the bone mass of 
appendicular skeleton increased. The remodelling of bone in these dogs was increased in the subchondral 
bone of the knee joint as was reported earlier (Oettmeier et al. 1992). Active recreational sports and 
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gymnastics regimes often train youngsters with a relatively high intensity today while the athletes are 
still in their adolescence. The effects of these programs on the developing locomotor system are not well 
known. Very few of the reports are longitudinal or they are on intensive exercise regimes. Even though 
exercise provides an effective way of enhancing bone mass, thus delaying the time taken to reach the 
postmenopausal fracture threshold, the benefit of exercise is lost if the training intensity is excessive 
leading to amenorrhoea or microdamage of bone and ultimately to loss of BMD (Bourrin et al. 1992, 
Christo et al. 2008, Drinkwater et al. 1984, Marcus et al. 1985, Rockwell et al. 1990).
Amenorrhoea in athletes is associated with a reduction in trabecular, but not in cortical, BMD 
(Drinkwater et al. 1984). In this experiment, the estradiol levels were lower in the trained beagles 
at the age of 55 weeks, even though dogs in estrus were excluded from the sample collection. It is 
possible that the lower estrogen levels at the age of 55 weeks reflected a maturational delay in the 
trained animals as compared with their untrained littermate sisters. However, at the end of the study, 
no significant differences were noted in the hormonal balance between the trained and control groups. 
On the other hand, in two earlier studies it has been shown that ovariohysterectomy in beagles does 
not induce significant alterations in bone mass or histomorphometry (Boyce et al. 1990, Shen et al. 
1992). Therefore, mechanisms other than estrogen deficiency, such as the local adaptation of bones to 
biomechanical forces, are suggested to be more important in causing the observed decrease in BMC and 
alterations in the elemental composition. The type of exercise, its intensity and the anatomical site where 
the stress is applied are important.
Bone turnover rate is considered to contribute to the variations of BMDs in the examined bones. 
Trabecular bone responds more rapidly to metabolic changes than compact bone. Therefore QCT was 
a more sensitive method than DXA for detecting changes in BMD, since the QCT measurements were 
carried entirely out of the trabecular bone of the vertebrae, while the DXA results represented a mean 
value for the total bone image under the scanner, which also included the cortical bone. The mean 
turnover rate of canine trabecular bone is reported to be 134% ± 94% per year (Kimmel and Jee 1982). 
In this study, a decrease in BMD was found in canine bones with a high turnover, e.g., os ileum and 
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vertebral bodies.
The inverse correlation between BMD and fracture risk is reported to be high (Alhava 1991, Cody 
et al. 1991, Hansson et al. 1987, Kröger et al. 1995a, Ott 1993). However, there are reports suggesting 
that the density measurements do not always relate to the biomechanical properties of trabecular or 
cortical bone (Carbon et al. 1990, Hui et al. 1988) and that other factors in addition to BMD contribute 
to the mechanical behaviour of bone. For example, most studies ignore the contribution of the collagen 
component in the determination of bone strength (Boskey et al. 1999).
In this study, PLM of bone revealed a more organized collagen network structure in the runner 
dogs than in their sedentary littermates. An improved organization may also affect mineralization pattern 
of the bones, since the hydroxyapatite crystals are arranged parallel to the long axis of the collagen 
fibrils (Bagambisa et al. 1993). However, bone histomorphometry detected no significant differences 
between the two groups in this respect. This study suggests that the higher organization of collagen fibrils 
maintained the biomechanical properties of the bone despite the lower BMD in the group of runner dogs.
Bone histomorphometry showed no significant changes in the cellular response of the vertebral 
bodies to long-term exercise. Dynamic analysis using tetracycline labelling would probably have 
provided more information on the mineralization of bone, but unfortunately this was not originally 
included in the study protocol.
Since the training took place when the dogs were still growing, the exercise may have caused 
alterations in the maturation of the different tissues. However, the dogs had ceased to grow when the 
most intense 40 km/day run started at the age of 55 weeks. Therefore the effect should be comparable to 
those encountered in young adolescents in modern sports. 
6.2 Effect of immobilization on bone (II)
Immobilization-induced osteopenia is a common adverse effect of fracture treatment. This 
results in site-specific bone loss in the unloaded limb. However, our study showed also bone loss in the 
contralateral limb in conjunction of the cast-immobilization. This finding is in accordance with earlier 
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reports (Mueller et al. 1992). Nonetheless, after a relatively long remobilization period (50 weeks), the 
difference in BMD between the splinted and weight-bearing contralateral limb could still be seen.
Bone histomorphometry showed increased bone formation and increased bone resorption of 
trabecular bone after immobilization. The higher bone turnover led to a remarkable bone loss during 
the immobilization period of 11 weeks. Remobilization reversed the situation and there were no 
differences in bone histomorphometry between the remobilized and control dogs. However, dynamic 
bone histomorphometry would perhaps have provided more detailed information about the rate of 
bone mineralization, but, unfortunately, the administration of fluorescent labels was not included in the 
original study protocol. Our results of bone histomorphometry after immobilization are in agreement with 
previous findings. Decreased bone volume was associated with the increased trabecular bone separation 
and a higher bone turnover, mainly due to unbalanced increase in bone resorption (Thomsen et al. 2005).
The accumulation of zinc in bone tissues of immobilized animals probably reflects the alterations 
in bone turnover, since zinc acts as a cofactor of ALP. Furthermore, zinc is required as a catalytic factor 
for MMPs that degrade matrix proteins. Thus both bone formation and resorption appear to eventually 
increase the zinc concentration in bone tissue.
6.3 Effect of proximal tibial osteotomy on bone (III)
The effects of proximal tibial valgus osteotomy on bone density and subchondral bone parameters 
were studied with a uniform group of beagles. The littermate sisters served as age- and sex-matched 
control animals. 
As a consequence of tibial valgus osteotomy, the tibiofemoral joint line was inclined laterally 
and also the mechanical axis of the operated limb shifted laterally. These alterations, together with a 
slight external rotation of paws of the operated limbs, resulted in a deranged pattern of joint loading in 
the knee joint, and subsequently cartilage failure (Panula et al. 1997). The evolution of degenerative 
cartilage defects due to altered joint biomechanics has been observed in several studies (Cooke 1985, 
Roach and Tilley 2007, Takai et al. 1985). The mean valgus tibial angle was 8° ± 1° in group of controls, 
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29° ± 5° in osteotomized and 15° ± 3° in sham operated dogs (Panula et al. 1997). Thus, in a few sham-
operated dogs, the valgus angle increased during the experiment, apparently on account of the fact that 
the osteotomy fixation was not sufficiently rigid to maintain the original position.
The gait pattern and weight-bearing of the limbs of the operated and control dogs after the 
operation were examined by using an electromechanical film technique to register the forces under the 
paws (Heikkinen et al. 1997). One month after operation, the animals were bearing 70% of the original 
weight with the operated limb. Three months after the operation almost no difference in weight-bearing 
could be detected between the operated and the contralateral hindlimbs.
The histomorphometry of subchondral bone of femur showed increased remodelling in this study 
(III). The changes were the greatest in the patellofemoral subchondral bone area suggesting an altered 
loading mechanism and/or a greater contact pressure at the patellofemoral joint. The changes in the 
BMDs of proximal femur indicated that alterations in the bone microarchitecture had taken place. It has 
been suggested that the primary OA can initially be also a bone disease rather than a cartilage disease 
(Lajeunesse and Reboul 2007). Previously, relatively little attention has been paid to changes in the 
subchondral bone. Bone changes have been considered to be secondary to the primary lesions observed 
in the cartilage. However, mechanical stress on weight-bearing joints may cause microfractures in the 
subchondral bone plate and in overlying cartilage. Progress of the sclerosis of subchondral bone plate 
increases bone stiffness, which, in turn, may contribute to injury and erosion of the cartilage. Also, 
healing of trabecular micro-fractures in the subchondral bone can result in a stiffer bone that no longer 
functions as an effective shock absorber (Radin et al. 1970, Radin and Rose 1986). 
6.4 Effect of altered or disturbed synthesis of type II collagen on bone (IV, V)
The effect of heterozygous inactivation of one allele of the type II collagen and incorporation to 
the murine genome of a transgene with a truncated human COL2A1 gene, was studied to find out the kind 
of role that type II collagen plays in bone development, modelling and remodelling. 
Although type II collagen is present only in a tiny amount in mature bone, it does have an 
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important role during bone development. During the maturation process, the cartilaginous model of bone 
consists mainly of type II collagen and it ossifies through endochondral ossification.
The physiological adaptation of bone to increased mechanical load, by increasing the bone mass 
or by arranging bone geometry, was not seen in the mice with HZ inactivation of Col2a1 gene. The 
running exercise caused an increase in the trabecular bone turnover. The production of type II collagen 
and probably also of PGs was disturbed. The PGs may have a specific role as a strain memory in the bone 
tissue and, thus, having a guiding influence on bone remodelling and organization (Skerry et al. 1988).
No significant differences were seen in the biomechanical parameters between the sedentary HZ 
Col2a1 knockout mice and their wt male controls. However, physical activity induced a significant 
decrease in the bone fracture resistance and stiffness among the HZ Col2a1 knockout mice, pointing 
to an important role for type II collagen not only in chondrogenesis but also in bone maturation 
and remodelling. The synthesis of type II collagen may be inadequate in knockout mice with a high 
remodellation rate, but the difference was further more balanced with advanced age.
Female HZ knockout mice and their wt sisters, on the other hand, had surprisingly high BMD and 
resistance to fractures compared to the male mice at the age of 9 months. Nevertheless, the difference 
seemed to diminish in older animals. This finding is in accordance with previous studies on female 
rodents and may be related to the production of estrogens (Järvinen et al. 2003a, Järvinen et al. 2003b, 
Wang et al. 2003). The production of estrogens by the female mice may contribute to the deposition of 
more minerals to bones during the growth phase.
6.5 Methodological discussion 
DXA has become the golden standard in bone densitometry. It has proven to be reliable and 
precise method in the evaluation of the BMD. However, DXA measures bone mass in relation to the two-
dimensional area in the path of X-rays. Any structural anomaly in the scanned area, bone exostosis or 
rotational malalignment may skew the BMD values. Thus, the settings of bone density measurement are 
critical (Bolotin et al. 2003, Bolotin et al. 2001). In addition, the role of the non-mineralized matrix in 
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the BMD measurement is not totally understood. The variation in the collagen content and arrangement 
may possibly affect the results of bone densitometry. In this study, we revaluated the use of a second-
generation DXA device for the determination of BMD in small animals. However, the mineral content of 
mouse bones was on the edge of the device sensitivity. Thus, when the number of specimens is limited, 
the use of DXA to analyze small animal specimens is not advisable. In QCT, an increased collagen 
concentration of bone may overestimate the BMD (Goodsitt et al. 1988).
In this study, we utilized the three-point bending test to determine the biomechanical properties 
of murine bones.  While this method is valid and well documented, it may give rise to methodological 
problems. In nature, diaphyseal bending forces sufficient to fracture bone occur only rarely without 
considerable shear stress. Usually the fractures emerge from a combination of bending, compressive and 
torsional loads. 
Animal models have been widely used to study basic phenomena involved in OP and OA. 
Even though the results have species-specific features, these studies contribute to the knowledge of the 
biology of bone and cartilage and may provide a fundamental basis for developing new treatments in the 
disorders of these tissues in humans. The statistical power of the results of the present study could have 
been stronger if the number of the experimental animals had been larger, especially in the experiments 
studying the loading effects on canine bone.
The genetic variability among mouse strains may have a major effect on bone mineral density 
(Beamer et al. 1996, Li et al. 2001). For example, the C57BL/6J mouse strain used in this study is a strain 
with one of the lowest bone mineral densities. Interestingly, similar variations in BMD and incidence of 
osteoporotic fractures have been observed also between different human races (Thomas 2007).
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7 SUMMARY AND CONCLUSIONS
In this study, five canine and murine models were utilized to evaluate the effect of functional 
loading on bone remodelling. This thesis work demonstrates that:
1.  Long-term running training of female dogs resulted in reduction in BMD in association with a 
slightly lower estradiol levels. However, the bone biomechanical properties remained unchanged 
possibly due to a higher degree of organization of the collagen matrix.
2.  Immobilization induced not only a site-specific reduction of BMD in the casted limb but also 
a decrease in the contralateral limb. Osteopenia was associated with increased bone formation 
and bone resorption in the immobilized limb, which reflected also the accumulation of zinc in 
bone. The bone changes were almost completely reversible after one-year of remobilization, but 
a difference in BMD between the immobilized and the contralateral limb could still be detected.
3.  Valgus osteotomy of the proximal tibia led to an increased turnover in the subchondral bone. 
Reduced BMD also in the proximal femur of the osteotomized limb was registered.
4.  Heterozygous knockout inactivation of one allele of the Col2a1 gene in association with running 
training of transgenic mice disturbed normal bone remodelling. The mutation also disturbed 
growth and produced a less organized collagen network when examined with the polarized light 
microscopy. The biomechanical properties of bone were also impaired.
5.  Truncated human type II collagen transgene in mice increased bone resorption and decreased 
bone formation. The transgenic mice were smaller and the biomechanical properties of bones 
were impaired. 
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